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• PDGF, platelet-derived growth factor. 
• TGF-β, transforming growth factor-beta. 
• αSMA, alpha-smooth muscle actin 
• ECM, extracellular matrix. 
• DPP4/CD26, dipeptidyl peptidase-4. 
• ITGB1/CD29, integrin beta-1. 
• ROS, reactive oxygen species. 
• CTGF, connective tissue growth factor. 
• FAP, prolyl endopeptidase/fibroblast activation protein. 
• CRABP1, cellular retinoic acid-binding protein 1.  
• COL11A1, collagen alpha-1(XI) chain. 
• LSP1, lymphocyte-specific protein 1. 
• SFRP2, secreted frizzled-related protein 2. 
• WIF1, Wnt inhibitory factor 1. 
• APOE, apolipoprotein E. 
• MFAP5, microfibrillar associated protein 5. 
• MEST, mesoderm-specific transcript. 
• ELN, elastin. 
• RGS5, regulator of G-protein signaling 5. 





Mammalian wound repair and scarring  
Tissue repair ensures restoration of form and function after acute or chronic injury. Repair 
encompass a kaleidoscope of different outcomes in the animal kingdom, ranging from tissue 
regeneration to fibrotic scars. Tissue regeneration represents the optimal outcome where, 
in response to injury, full restoration of form and function occurs. For example, whole body 
regeneration in planaria or colonial ascidians (1; 2) and limb regeneration of 
salamanders/newts (3). Repair could also involve restoring of the main function of the 
damaged tissue in absence of morphologic regeneration. Examples of such a repair process 
is lung and liver compensatory growth. Here, after a lobectomy or a partial hepatectomy the 
remaining organ capacity is increased to compensate for the missing tissue without 
recovering the original form (4; 5). Interestingly, higher vertebrates such as mammals 
generally favor functional over morphologic regeneration. The ability of some species to 
regenerate whole tissues/organs, and its absence in humans, has inspired scientists for over 
a century to understand and improve the reparative processes in humans (6). 
Another clear example of a reparative process in mammals is skin wound healing, in which 
the main function as an external barrier is quickly restored without regaining the original 
architecture. Indeed, skin wounds usually do not regenerate secondary appendages such 
as hair follicles and sebaceous glands. Instead, skin wounds repair by depositing a dense 
plug of fibrous tissue that seals the injury site with a scar (7). 
The extensive accretion and deposition of extracellular connective tissue (termed fibrotic 
scar), severely affects the normal physiology of numerous organs, and it often leads to a 
decreased life expectancy (8). Besides esthetical and psychological concerns, pathological 
skin scars such as keloids, hypertrophic scars, and skin contractures severely impair normal 
movement and lifestyle of an individual (9). On the other side of the spectrum, when the 
wound healing and scarring process are compromised, and the external barrier function of 
the skin is not quickly restored, life-threatening non-healing chronic wounds expose patients 
to persistent infections, poor thermoregulation, and fluid loss (10). Considering both 
pathological skin fibrosis and non-healing chronic wounds, estimates indicate an economical 
burden for wound care between $28.1 billion to $96.8 billion in the U.S. alone (11). Thus, is 
imperative to increase our understanding on the basic biological mechanisms of skin wound 
repair, which in turn would lead to innovative approaches to restore a healthy repair process 
in patients with either excessive scarring or non-healing wounds. 
The current wound-healing model is divided in three consecutive and overlapping stages 
(12). In the initial inflammatory stage, platelets released from adjacent damaged blood 
vessels aggregate during the coagulation process leading to the formation of a fibrin clot 
that works as a provisional matrix, this in turn allows cell infiltration into the site of injury. 
Concurrently, influx of initially neutrophils and later monocytes, contribute to tissue clearance 
and pathogen removal. In the following proliferative stage, the barrier function of the 
damaged area is restored. Contraction of the provisional matrix mediated by myofibroblasts, 
a transient fibroblast state linked to scar formation (13), gradually decreases the repair area 
and closes the wound. Simultaneously, neo-angiogenesis in the provisional matrix ensures 
normoxia of the new tissue. Finally, re-epithelialization onto the new tissue via keratinocyte 
migration establishes a new skin barrier. In the last remodeling stage, the scar formation is 
accreted, local apoptosis in the wound bed decreases the cellular density in the scar tissue 
and the matrix composition becomes enriched in collagen type I in a dense and regular 
conformation of parallel thick fibers. 
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Not all wounds scar 
Wound repair in the skin is highly contextual. It depends on the injury type, anatomic location, 
age, and the species. All these parameters dictate the severity of scarring or scarless 
regeneration. The current basic and clinical thinking is that this diversity of responses in the 
skin is mediated by different environments. However, as you will see bellow, this conclusion 
seems incorrect. Instead, a new picture is emerging where mixtures of heterogeneous 
populations of fibroblast dictate the responses of skin tissues to either scar or regenerate. 
This, in fact, represents a paradigm shift in our understanding of wound repair. 
Ontological discrepancies 
More than six decades ago and inspired by the regenerative capacity of salamanders, Arthur 
Hess questioned whether the regenerative capabilities of these lower forms was also 
present in a “more primitive” mammalian form, the fetus (14). Hess inflicted injuries in utero 
on the back of guinea pig embryos and, although he failed to detect a regenerative response 
similar to amphibians, he noticed a “greater growth (healing) potential than those of 
postnatal animals”. In the following decades, these observations were replicated in opossum 
(15), rat (16; 17), rabbit (18; 19), lamb (20), primates (21; 22), and observed in human as well (23). 
The common theme across several species was a lack of a robust immune response and 
minimal or absence of scar tissue (termed scarless repair). 
Initially, it was believed that the fetal environment could promote scarless repair due to the 
inherent sterile nature, low oxygen levels, and high growth factors present in the amniotic 
fluid; all of which are variables known to directly affect the scar repair in adults (24). A series 
of heterochronic (young-to-old) grafting experiments later showed that embryonic skin repair 
scarlessly in the adult environment (25), and conversely, adult skin generates scars in the 
fetal setting (26). These results demonstrated the minimal influence of the environment for 
the repair outcome and, furthermore indicated that inherent changes in the embryonic and 
adult skin are responsible for the respectively scarless regeneration and scarring repair 
responses. 
Interestingly, it was observed that the scarless regeneration potential decreases at later 
gestational stages. Injuries on mouse and rat E16.5 embryos (16.5 days post coitum, 76% 
of full term) regenerate scarlessly while injuries in E18.5 embryos (86% of full term) 
resembled adult wounds with scars (27; 28). Similar transitions from regeneration-to-scarring 
were observed in fetal lambs between 69-83% of full term (29), in 51-60% of full term rhesus 
monkeys (22), and in 55-64% of full term or beginning of third trimester in human (25). These 
observations lead to the hypothesis of a regeneration-to-scar transition during late 
development as conserved in all mammals, where the intrinsic mechanisms that regulate 
the scarring repair response in the skin are established. 
An inverse scar-to-regeneration transition appears to occur much later in life. Wound healing 
studies performed during World War I indicated an inverse relation between the closure rate 
of wounds and age (30). Several animal models have corroborated that aged mammals 
repair wounds slower than younger ones (31). This slow closure has been assumed to occur 
because of cell intrinsic changes such as impaired cell migration, cellular senescence, 
delayed cytokine secretion; and systemic changes such as hormone levels decline, and a 
weakened immune system and inflammatory response (24). The delayed repair in aged 
organisms often leads to an improved tissue repair with diminished scar tissue formation (32; 
33; 34). Nonetheless, co-morbidities in aged individuals, such as diabetes, completely 
worsen the repair response and result in non-healing chronic wounds (35) making the wound 
healing outcomes in aged individuals highly variable. Altogether, the scar-forming aptitude 
of the skin seems particularly augmented throughout the early postnatal life to mid-
adulthood as a possible evolutionary mechanism to ensure survival of the organism during 
the most vulnerable and later reproductive stages. Then, injuries preluding the 
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establishment of this mechanism or after their decline would allow other scarless reparative 
processes to take place. 
Phylogenetic and anatomical discrepancies 
Scar-mediated repair has been observed in several mammalian species such as horses (36; 
37), rodents (38; 39), dogs (40), sheep (26), and primates (41). These observations suggest that 
scar-mediated repair is a common ‘mono-phyletic’ trait that has emerged once in mammals. 
Nonetheless, extraordinary instances of full regeneration were documented in few mammals. 
For example, male deer undergo annual rounds of antler shedding and regrowth as part of 
their reproductive cycle. The fast-growing appendages include not only bone but blood 
vessels and a specialized velvet skin, thus represents a full organ regeneration without the 
formation of scar-like tissue (42; 43). A second example of skin regeneration has been 
observed in hibernating black bears after inducing full-thickness excisional wounds and fully 
restoring the native architecture of the skin including hair follicles (44). 
The most deeply studied case of full skin regeneration in a mammal belong to the African 
spiny mouse from the genus Acomys. Members of this genus have adapted a skin autotomy 
strategy, or self-shedding, to prevent predation. The skin shedding generates open wounds 
that can cover up to 60% of the dorsal surface. These wounds quickly heal, and all cell types 
and appendages of the skin in the injury area are fully regenerated without scar tissue 
formation (45; 46; 47). This incredible feat has been directly compared to the wound healing 
process in the common laboratory mouse Mus musculus to reveal important mechanisms 
that could be responsible or facilitate skin regeneration. These differences include a low 
presence of pro-inflammatory leukocytes such as neutrophils and macrophages in Acomys, 
and poor cytokine release with an anti-inflammatory profile in the spiny mouse wounds (48; 
49). Acomys wounds also present low collagen deposition and high protease expression, 
and low conversion rates of fibroblasts into scar-producing myofibroblasts (50; 51; 52). All 
these observations lead to the hypothesis that skin regeneration in Acomys resembles the 
fetal wound healing response and suggests that retaining these characteristics into 
adulthood is feasible and if extended to humans-would enable natural scarless regeneration 
in the skin. 
Variances in the scarring outcome exist at different anatomical locations, even within a single 
organism. In contrast to the scar-forming repair in cutaneous skin such as the back-skin, 
injuries in the oral mucosa resolve without scar formation, even in adults (53; 54). Furthermore, 
within the oral cavity there are striking differences in the wound healing rate between hard 
and soft palate tissues, with soft palate tissue repairing wounds much faster (55). Just like 
Acomys skin, the oral mucosa repair has been compared to fetal healing. Oral mucosa 
wound healing displays limited immune responses and a particularly faster re-
epithelialization (56; 57; 58). These observations suggest that the scarless repair mechanisms 
are not restricted to the embryonic environment or differentiation status and thus could 
potentially be induced in adulthood and extended to different human organs. 
Injury severity  
Another factor that directly determines the occurrence of scars is the area and depth of the 
insult. For example, larger and deeper wounds are more susceptible to develop larger scars. 
As example of diverse scarring responses across anatomic depths occurs in the cornea. 
Injury-induced corneal scarring is a major determinant of corneal blindness, which is second 
only to cataract as the leading cause of blindness  (59). The prevalence of corneal scarring 
induced after repair depends on the severity and depth of injury (60). Similar to skin 
(discussed below), the anatomy of the cornea is composed of a stratified external epidermal 
wall sustained underneath by a stromal layer (59). Penetrating injuries that pierce through 
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both layers present the highest prevalence of corneal scarring, while more superficial injuries 
by blunt-force ruptures show lower incidence of scars (61).  
Pathological scars, such as hypertrophic scars and keloids, are frequent sequels of severe 
skin burns and thus a huge effort has been done to prevent and manage these fibrotic 
pathologies (62). Burn severity parameters, such as percentage of total body surface area 
affected and injury depth (partial or full-thickness injury), directly correlate with a more 
severe scarring outcome; independently of other factors such as burn type (scald or flame), 
age, or sex (63; 64; 65). Scar contractures, a complication of large hypertrophic scars that 
harshly limits the body movement (66), also prevail in burn victims with a higher burn severity 
(67). 
The correlation between injury depth/extent and scar severity occurs not only in burn injuries 
but also in incisional/excisional wounds. The human skin includes three functionally 
discreate layers: epidermis, dermis, and hypodermis (68; 69). The epidermis is composed of 
a stratified epithelium. It hosts several keratinocyte subpopulations that range in depths from 
0.075 - 0.15 mm up to 0.6 mm in hairless thick skin such as the skin on the palms and soles. 
This layer is considered highly regenerative and injuries are quickly repaired via keratinocyte 
proliferation and migration (70). The dermis lays bellow the epidermis. It is a connective 
tissue layer that extends in humans between 1 to 4 mm in thickness, depending on the 
anatomical region. This compartment has been classically subdivided into two main 
anatomical layers: papillary and reticular dermis. The most superficial papillary dermis, 
adjacent to the epidermis, is a thin layer (0.3 - 0.4 mm thick in humans) that contains thin 
collagen fibers densely packed that connects the deeper reticular dermis encompassed by 
thicker fibers organized in interwoven bundles. The complex extracellular matrix lattice of 
the dermis is produced and maintained by resident fibroblasts and supports extensive 
neurovascular and lymphatic networks, and secondary skin appendices such as hair follicles 
and sebaceous glands. Scars usually develop when injuries traverse this deeper reticular 
layer. Indeed, measurements in humans indicate a critical injury depth of at least 33% of the 
total epidermis-dermis thickness is required to generate visible scars (71). This indicates that 
injuries penetrating only the epidermis, papillary dermis, and partially the reticular dermis 
can repair scarlessly. The innermost layer that connects dermis to the musculoskeletal 
system bellow the skin, is the hypodermis. It is comprised of loose collagen fibers, resident 
fibroblasts, macrophages, and fat tissue. Although severely understudied as compared to 
papillary and reticular dermis, the main functions of the hypodermis relate to interstitial fluid 
control and thermoregulation. Even though some fibrotic pathologies in this layer have been 
described, such as in localized scleroderma (72) or Dupuytren's contractures (73), the role of 
this layer in the typical cutaneous scar process remains highly unexplored.  
The above direct correlation between injury depth and scar tissue severity suggests that the 
intrinsic scar-free reparative mechanisms in mammals are restricted to skin layers. It is only 
when an injury surpasses the capacity of the regenerative processes that the scarring repair 
takes place, possibly, because scarring occurs much faster than regeneration. Approaches 
that enhance the scar-free healing, or that prevent the scarring mechanisms from ensuing 
could in principle improve the regenerative capacity of mammalian tissues and organs. 
(Myo)fibroblasts as cellular inducers of scars 
These contradictory findings can be understood considering the complex cellular activities 
that occur in wounds, especially of myofibroblasts, the scar producing cells in wounds and 
the main determinants of scar vs. scarless repair. The “myofibroblast” term was coined by 
Giulio Gabbiani in his seminal works where he detailed a fibroblast population with 
cytoskeletal attributes resembling smooth muscle cells. Gabbiani noticed that these unique 
fibroblasts locally emerge in wounds and then disappear during the cutaneous wound 
healing process, suggesting a pivotal role on wound contraction (74; 75). Ever since, 
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myofibroblasts have been detected in virtually every fibrotic pathology of any organ and their 
sustained or augmented presence directly correlates with a more severe fibrosis (76). The 
cellular source of these myofibroblasts have been a controversial field for the last decades. 
Depending on the organ and injury model, more than one possible source has been reported 
(77; 78; 79; 80; 81; 82; 83; 84). Nonetheless, the more consistent and prominent source of 
myofibroblasts are resident fibroblasts (85; 86; 87; 88; 89; 90; 91; 92). 
Myofibroblast conversion in response to injury starts with the activation of resident 
fibroblasts. Fibroblasts are the primary cells that synthesize, secrete and remodel the 
extracellular matrix in all tissues and organs of the body (93). Damage-induced stress signals 
such as platelet-derived growth factor (PDGF) and changes in tissue stiffness activate 
fibroblasts. These activated fibroblasts or proto-myofibroblasts migrate into the damaged 
tissue and secrete new ECM components. Further local signals like the transforming growth 
factor-beta (TGF-β) prompts their maturation into mature myofibroblasts, characterized by 
their contractile apparatus and expression of alpha-smooth muscle actin (αSMA). At later 
stages of the wound closure, myofibroblasts recede via a non-completely understood 
process (76). 
Altogether, myofibroblast derived from resident fibroblasts directly affect the repair outcome 
making them attractive to understand the discrepancies of the mammalian repair responses. 
Not all fibroblasts scar, fibroblast heterogeneity to understand repair discrepancies 
Classically, fibroblasts have been phenotypically described as dedicated extracellular matrix 
(ECM) producers but with the advent of new technologies, such as marker screening 
methods, genetic lineage tracing, multi-omics tools, and more recently single-cell 
transcriptomics, an unexpected functional heterogeneity in this cell type has surged in the 
last decades (93). This new appreciation on the multifaceted nature of these cells have not 
only boosted our understanding on their role during the wound healing process but give us 
a new direction to explain the different repair outcomes in mammals. 
Ontological fibroblast heterogeneity: Scarless fetal/aged dermis versus scarring adult dermis 
Fibroblasts isolated from embryos at scarless stages express higher levels of TGF-β, and 
particularly TGF-β3, compared to adult or neonatal fibroblasts that heal wounds with scars 
(94; 95; 96). TGF-β isoforms are multifunctional growth factors that regulate cell proliferation, 
migration, differentiation, extracellular matrix (ECM) production, and the immune response. 
TGF-β3 has been linked to scarless repair, whereas TGF-β1 is known to promote fibrosis 
(97). Despite fetal fibroblasts expressing higher levels of TGF-β isoforms than adult 
fibroblasts, they proliferate slower in response to TGF-β stimulation (98). Interestingly, old 
fibroblasts have a lower expression of growth factors than adult fibroblasts, including TGF-
β (99; 100). Furthermore, damage accumulation during aging leads to a buildup of senescent 
fibroblasts in the dermis (101; 102; 103; 104; 105), indicating that diminished proliferation, due 
to a low responsiveness to or lower expression of growth factors, is a shared characteristic 
in scarless repair-related fibroblasts. ECM production in fetal and aged fibroblasts is also 
different than adult fibroblasts. Fetal fibroblasts express higher levels of collagen III while 
late-gestational, neonatal, and adult fibroblasts express mainly collagen I (106; 96; 107). 
Similarly, old fibroblasts have reduced collagen expression compared to adult fibroblasts 
(108; 34; 109). Altogether, a poor growth factor production/responsiveness, low proliferation, 
and diminished ECM production might account for the heterogeneity of fibroblasts and 
license scarless skin repair. 
Fetal fibroblasts migrate faster than their adult counterparts (110) and are not inhibited by cell 
density (111) while aged fibroblast migration is highly variable depending on the donor (112; 
113). More recently, a report showed that wound closure rate in aged mice is highly variable 
and fast healers possess dermal fibroblasts with signatures of proto-myofibroblasts 
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(migratory and proliferative) compared to slow healers (34). This suggest that fibroblast 
heterogeneity in aging might be vastly influenced by extrinsic factors such as lifestyle, 
nutrition, and environmental influences (101). Indeed, it was shown that caloric restriction in 
old mice can maintain fibroblasts with a transcriptomic profile more similar to young 
fibroblasts (108). Fetal fibroblasts and in vitro aged fibroblasts possess poor contractility (114; 
115; 116; 117; 118) but no differences were detected in primary fibroblasts from old and adult 
donors (119). Nonetheless, poor migratory fibroblasts from old donors showed a reduced 
contractility compared to robust migratory aged fibroblasts (113) indicating that contractility 
might be also influenced by extrinsic factors during aging. Thus, in the case of migration and 
contractility, although important for the wound healing process, are not consistent traits in 
fibroblasts from scarless stages. 
In summary, several intrinsic differences in fibroblasts from different ontological stages 
uncovered clues regarding cell processes that might influence the scarless repair outcome, 
yet little attention has been given to what mechanisms drive these changes in the fibroblasts. 
Furthermore, most work in both fetal and aged fibroblasts derive from in vitro studies that 
might just partially recapitulate the in vivo process. In the case of aged fibroblasts, general 
age-related effects such as chronological senescence, accumulated DNA alterations and 
protein modifications might induce these observed changes (101). On the other hand, it was 
assumed that the transition from scarless- to scar-producing fibroblasts in late embryonic 
development may well be a matter of maturation of the same fibroblast population, yet an 
alternative hypothesis could be the existence of non-overlapping populations with different 
scarring abilities. In the present Publication I, we explored this question and provided in 
vivo evidence supporting the latter option in the back-skin. We showed that fibroblasts from 
scarless-repairing embryonic stages get transiently replaced by a mature population of scar-
forming fibroblasts (120). Interestingly, a similar replacement mechanism was reported to 
occur in aged fibroblasts where the amount of dipeptidyl peptidase-4 (DPP4/CD26) positive 
fibroblasts, linked to scar formation in adult mice, get replaced in old mice by integrin beta-
1 (ITGB1/CD29) expressing fibroblasts (121). Thus, the repair outcome discrepancies along 
ontology seemed to be caused by the exchange of intrinsic different fibroblasts populations, 
rather than a change in their physiology. 
Phylogenetic and anatomical fibroblast heterogeneity: Acomys versus Mus and gingiva versus dermis 
Reports comparing Acomys to Mus musculus fibroblasts, indicate that fibroblasts from 
Acomys proliferate more in culture than mouse fibroblasts and have an enhanced resistance 
to reactive oxygen species (ROS)-induced senescence. This resistance was linked to an 
intrinsic mitochondrial protection and an improved intracellular detoxification against ROS 
(122). A carefully regulated ROS production modulates the mammalian wound healing 
process (123) and an excessive production or impaired detoxification results in non-healing 
chronic wounds (124). Counterintuitively, in vivo ROS production in wounds is higher in 
Acomys than mice (49), suggesting that the intrinsic ROS resistance in Acomys fibroblasts 
might be an evolutionary adaptation to the high ROS production in these animals. ROS-
mediated redox signaling mediate fibroblast conversion into myofibroblast, including αSMA 
expression (125). Still, Acomys fibroblasts showed lower αSMA expression in in vivo (45) and 
in cultures (126), thus, it is plausible that the enhanced ROS clearing in Acomys fibroblasts 
prevent their conversion into myofibroblasts and, as a result, avoid scar tissue formation.  
Unlike the mesoderm origin of dermal fibroblasts, gingival fibroblasts originate from the 
neural crest (127) and their neuroectodermal origin endows them with an intrinsic 
regenerative potential (128). Indeed, reciprocal transplantations of gingival fibroblasts into 
the skin further showed their intrinsic propensity to scarless repair, even when placed into a 
scarring environment such as the back-skin (91). Analogous to Acomys fibroblasts, gingival 
fibroblasts are resistant to ROS detrimental effects (129) and express higher levels of ROS-
related genes compared to dermal fibroblasts (130) indicating that higher ROS production 
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and an intrinsic cellular adaptation to prevent ROS-induced toxicity are common traits in 
scarless scenarios. ROS also mediate αSMA expression in both human gingival and dermal 
fibroblasts (131). Yet, unlike the Acomys equivalents, gingival fibroblasts have a constant 
expression of αSMA in vitro, compared to the transient expression in dermal fibroblasts, and 
they also express higher levels of ECM-remodeling enzymes (132), suggesting that a more 
efficient matrix remodeling prevents scar formation in the oral mucosa. Analogously, models 
of lung fibrosis in mice often restore the original organ architecture and ECM-remodeling is 
believed to be a crucial step on this endeavor (133). These comparative studies imply for 
high ROS levels as drivers of scarless repair by preventing fibroblast-to-myofibroblast 
conversion (as in Acomys) and by improving ECM remodeling (as in the oral mucosa). 
Injury depth-related fibroblast heterogeneity: papillary versus reticular versus hypodermal 
fibroblasts 
Fibroblast heterogeneity within the skin further helps to understand the repair discrepancies 
occurring in response to different injury depth. Papillary fibroblasts from the superficial 
papillary dermis proliferate more than reticular fibroblasts, migrate faster, and are more 
resistant to apoptosis but are less contractile and express lower levels of ECM components 
(134; 135; 136; 137; 138; 139; 140; 141; 142). Papillary fibroblasts sustain basement membrane 
production and epidermal morphogenesis in vitro (143; 141; 144), indicating that this 
population might be specialized in epidermal homeostasis. Papillary fibroblasts are more 
sensitive to deleterious effects of aging and in vitro prolonged culture acquiring phenotypes 
similar to reticular counterparts regarding low proliferation, contractility, and epidermal 
morphogenesis sustenance (145; 146; 147). 
Human deep skin fibroblasts (2-3 mm in depth, most likely reticular and or hypodermal 
fibroblasts) proliferate less than superficial fibroblasts (< 1.5 mm in depth, reticular and 
papillary-likely populations) and express higher levels of collagens, αSMA, and profibrotic 
growth factors like TGF-β1 and connective tissue growth factor (CTGF); these 
characteristics makes deeper fibroblasts more comparable to fibroblasts extracted from 
hypertrophic scars (148; 149). Similarly, pig fibroblasts from the “deep dermis” 
(reticular/hypodermal) express higher amounts of αSMA in vivo upon injury and produce 
thicker scars than superficial (papillary/reticular) fibroblasts (150; 151). In comparison, human 
hypodermal fibroblasts proliferate less than both reticular and papillary fibroblasts, are less 
contractile and poorly sustain epidermal morphogenesis. Nonetheless, from the three 
subpopulations hypodermal fibroblasts have the highest in vitro differentiation potential to 
other mesenchymal cell types such as adipocytes, osteocytes, and chondrocytes (152). 
Altogether, the traits of deeper fibroblasts resemble characteristic of myofibroblasts and 
implies these subpopulations predominantly contributes to cutaneous scar formation. 
Papillary and reticular fibroblasts possess distinct molecular signatures (153; 154) and higher 
expression of common fibroblast markers such as prolyl endopeptidase/fibroblast activation 
protein (FAP) and CD90/THY1 have been used to discriminate between papillary and 
reticular fibroblasts respectively (155).  
With the advent of single-cell transcriptomics, a more complex fibroblast heterogeneity and 
new molecular identifiers have recently emerged. Studies using human skin report 
inconsistent numbers of fibroblast subpopulations. Tabib and colleagues reported two major 
subpopulations in the forearm dermis (156; 157), while He et al. and Solé-Boldo et al. reported 
four subpopulations in arm and inguinoiliac skin respectively (158; 109). A fourth study by 
Vorstandlechner and colleagues further expanded the kaleidoscope of fibroblastic types by 
identifying six subpopulations in the ventral skin (abdomen) (159).  
However, many of these populations may include other mesenchymal residents of the skin 
besides interfollicular fibroblasts. Tabib et al. detected a population expressing both cellular 
retinoic acid-binding protein 1 (CRABP1) and collagen alpha-1(XI) chain (COL11A1) while 
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He et al. and Solé-Boldo et al. also detected a subpopulation marked by COL11A1 
expression. CRABP1 is highly expressed in the dermal papilla and COL11A1 in the dermal 
sheath, two closely related mesenchymal cell types dedicated to hair follicle sustenance (160; 
161), while lymphocyte-specific protein 1 (LSP1) marks for the other major subpopulation in 
Tabib et al. study which is also a marker of fibrocytes (162). These findings argue against 
CRABP1/COL11A1- and LSP1-positive clusters being true interfollicular fibroblast 
subpopulations. 
Previously detected interfollicular fibroblast markers such as secreted frizzled-related 
protein 2 (SFRP2), DPP4/CD26, and Wnt inhibitory factor 1 (WIF1) were detected in half of 
the subpopulations of Tabib et al. and Vorstandlechner et al. reports while Solé-Boldo et al. 
reported one WIF1 positive cluster. All these markers have been reported to be highly 
expressed in fibroblasts in diverse skin fibrotic conditions (163; 164; 165; 166; 167; 91; 168; 169; 
170; 90), suggesting their likely involvement in scar formation.  
Novel potential fibroblasts subpopulations were also detected. Apolipoprotein E (APOE) 
marked a single population in He et al. and Solé-Boldo et al., and two subpopulations in 
Vorstandlechner et al., while a microfibrillar associated protein 5 (MFAP5) expressing 
subpopulation was detected in all three reports. Functional characterization of cells 
expressing these population-restricted markers is still missing and would allow definitive 
assignments as true fibroblast subpopulations. 
From these four studies, only Solé-Boldo and colleagues could assign each subpopulation 
with a distinct skin compartment. Using RNA-fluorescence in situ hibridization they traced 
the COL11A1 population into hair follicles, supporting the idea of this population 
representing both dermal papilla and dermal sheath cells. The WIF1 population allocated in 
the papillary dermis while MFAP5 expressing cells populated the reticular dermis. The pro-
inflammatory APOE population was strongly associated with blood vessels suggesting it 
might represent a perivascular fibroblast population. 
Single-cell transcriptomics from healthy mouse skin added further complexity to the classical 
papillary and reticular division. Two superficial subpopulations, that reside in the papillary 
and superficial reticular dermis, showed dynamic changes linked to the hair cycle, while two 
deeper static subpopulations reside in the deep reticular layer and hypodermis (171).  
Studies from mouse wounds reported the existences of three to five different fibroblast 
subpopulations (172; 173). Guerrero-Juarez et al. showed that a subpopulation expressing 
CRABP1 reside in the upper section of the wound (thus devoid of hair follicles and mature 
dermal papilla) while the deeper layers were populated by a subpopulation expressing 
mesoderm-specific transcript (MEST) and elastin (ELN). Gay et al. also showed a 
subpopulation of fibroblasts expressing ELN, suggesting that this deep subpopulation 
remains static during later stages of wound healing. Nonetheless, these studies neglected 
other mesenchymal residents during the analysis making the real number of fibroblasts 
subpopulations likely lower. Guerrero-Juarez et al. described a population marked by the 
expression of regulator of G-protein signaling 5 (RGS5), which has been previously 
described to be a pericyte marker (174) and Gay et al. reported a transgelin (TAGLN) and 
αSMA expressing population, yet these two markers are co-expressed by the dermal sheath 
cells (171). 
In summary, deeper fibroblast populations and particularly reticular fibroblasts have been 
linked to fibrosis (90). This would explain why critical injury depths are needed to induce scar 
formation. Although the cellular characteristics of hypodermal fibroblasts make them more 
similar to reticular fibroblasts, there has been limited number of studies that test whether 
this population could play a role in scar formation in vivo. In the accompanying Publication 
II we tested this hypothesis and proved that fibroblasts from the hypodermal connective 
tissue, termed fascia, populate wounds of deep injuries and they intrinsically generate large 
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scars whereas superficial wounds resolved in smaller scars by fibroblasts from the dermis 
(175).  
Aims 
To understand the influence of fibroblast heterogeneity and their relation to different repair 
outcomes, we aimed to characterize the origin of scar-forming fibroblasts in cutaneous 
wounds. First, we proved during development, that scar-forming fibroblasts outcompete 
native regenerative populations of dermal fibroblasts. Furthermore, we showed that this 
transition from regenerative-predominance in fetal tissues to scarring-predominance in adult 
tissues results from a transition between 2 distinct fibroblast communities, which shape 
dermis maturation and progressively transitions the response of skin wound, from 
regeneration-to scarring. This novel cellular replacement mechanism explains the 
regeneration-to-scarring transition on the premise that regenerative-prone fibroblasts get 
replaced by a scar-preferring population late in development. 
In the second publication, we delve deep into the diversity of wound responses across skin 
depths. We show that on one hand, when injuries are superficial, the classical de novo matrix 
deposition is orchestrated by the dermal fibroblasts, culminating in smaller scars. On the 
other hand, when injures are deep, a novel mechanism driven by fibroblasts in the deep 
areas of the hypodermis initiates, in which plugs of mobile tissue patch the open wound and 
serve as a provisional matrix that generates larger scars. 
These observations provide a better understanding of the basic biology of the scar-forming 
fibroblasts and wound repair. The generated knowledge would provide innovative 
approaches to tackle pathological scarring conditions such as hypertrophic scars, scar 
contractures, and keloids, to restore the reparative prowess in non-healing chronic wounds, 
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In the presenting work my contribution included: 
 




a) Fig.1 d-f: histological analysis to describe the role of cell proliferation and apoptosis 
in the increase and decrease of the EPF and ENF populations respectively during 
development.  
b) Supp Fig.2: immunodetection of classical fibroblast markers to depict EPF and ENF 
heterogeneity. 
c) Supp Fig.3: histological analysis showing the direct correlation between EPF invasion 
and Collagen I deposition in the developing dermis. 
d) Fig.4 and Supp Fig.5: Implementation of fractal analysis to describe collective 
cytomorphological changes during dermis development. 
e) Supp Fig.6: histological analysis showing the EPF influence on the fibronectin matrix 
stiffness during development. 
f) Fig.5 g-i: Ex vivo explant culture to functionally prove the anterior-to-posterior scar-
prowess acquisition of the dermis associated with the anterior-to-posterior EPF 
invasion. 
g) Fig.5 f,i, Fig.6 f, and Fig.7 d: Implementation of fractal analysis to describe ECM 
changes related to fibrosis. 
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During fetal development mammalian back-skin undergoes a natural transition in response 
to injury, from scarless regeneration to skin scarring. Here we characterize dermal 
morphogenesis and follow two distinct embryonic fibroblast lineages, based on their history 
of expression of the Engrailed1 gene. We use single cell fate-mapping, live 3D confocal 
imaging and in silico analysis coupled with immuno-labelling to reveal unanticipated 
structural and regional complexity and dynamics within the dermis. We show that dermal 
development and regeneration are driven by Engrailed1-history-naive fibroblasts, whose 
numbers subsequently decline. Conversely, Engrailed1-history-positive fibroblasts possess 
scarring abilities at this early stage and their expansion later on drives scar emergence. The 
transition can be reversed, locally, by transplanting Engrailed1-naive cells. Fibroblastic 
lineage replacement thus couples the decline of regeneration with the emergence of 




Skin develops in fetus when dermal fibroblasts establish a porous, ‘basket-weave’ 
scaffold, providing the tensile strength and extensibility needed for the structural integrity 
and for protective and sensing functions. Injuries to the skin commonly lead to loss of these 
frameworks and replacement by scar tissues, which have greatly limited functions. Scar 
tissue is rarely observed in lower vertebrates, where the normal response to injury is a 
complete regeneration of the original dermal structure. Mammals however have evolved to 
heal with scar tissue and undergo a regeneration-to-scar phenotypic transition during fetal 
life1-2. This transition has been documented in the back-skin of all mammalian embryos 
studied to date including human3-7.  
Previous studies into the fetal commencement of scarring have focused on a multitude of 
environmental differences between early and late fetal stages, including inflammatory 
responses to injury, expressions of morphogenetic proteins, growth factors and extracellular 
matrix (ECM) components such as hyaluronic acid8. In the early 90s, Longaker and 
colleagues addressed the influence of the environment on the commencement of scarring 
by performing fetal/adult heterochronic transplantations of back-skin tissues in sheep. They 
found that donor back-skin tissues respond to injury (scar/regenerate) independent of host 
microenvironment or developmental stage. They thus concluded that the determining 
factor/s of the commencement of scarring are likely intrinsic to the transplanted back-skin 
graft, most likely its fibroblasts, the tissue’s primary secretors of ECM9-10. 
More recently, we have discovered that functionally diverse lineages of fibroblasts coexist in 
the mouse back-skin and oral cavity11. Embryonic cells that have expressed Engrailed-1 
(En1), termed EPFs (En1-lineage-Past fibroblasts) are the primary contributors to scarring 
in various models of pathologic scars. Conversely, En1-lineage-Naive fibroblasts (ENFs) do 
not participate in scar production. By transplanting adult ENFs or EPFs in different 
anatomical locations, we determined that the difference in the capacity of EPFs & ENFs to 
form a scar in vivo is cell-intrinsic and permanent11.  
Here, we followed the fates of EPF & ENF progenitors. We used genetic fate-mapping 
approaches at single cell and lineage levels, live 3D confocal imaging of lineage-specific 
cellular migrations and immuno-labelling coupled with in silico approaches to determine how 
the dermal structure in the back-skin develops. We find that ENFs form the sculptures of the 
dermal lattice and that their cell lineage declines during development, concurrent with a 
surge in EPF numbers that predisposes back-skin to scarring.  
 
Results 
ENFs are replaced by EPFs during back-skin development 
The En1 gene is expressed in a small subset of early embryonic cells and switched off 
permanently later in embryogenesis11. To distinguish En1-expressing cells and follow their 
fibroblastic descendants in the developing back-skin, we used a transgenic mouse system 
where En1 expression drives genetic rearrangements (En1Cre). Crossing En1Cre with a 
reporter mouse system (R26mTmG), generated offspring where the genetic rearrangement 
replaced membrane bound tomato red protein (RFP) expression with membrane bound 
green fluorescence protein (GFP) expression12 (Fig. 1a). The permanent replacement of 
RFP with GFP in all descendant cells allowed purification schemes of EPFs and ENFs based 
on GFP+RFP-Lin- and GFP-RFP+Lin-, respectively.  
We thus performed flow cytometric analysis of EPFs and ENFs from the total fibroblast 
population (Lin-, see Methods) in early fetal back-skin. Dermal fibroblasts were mostly ENFs 
early on, and they declined slowly during subsequent development, followed by a steep 
decline between E14.5-E18.5 (~90% down to ~20%, Fig. 1b-c). The drop in ENFs was 
proportional to total dermal cells (including hematopoietic, endothelial, lymphatic) and to 
dermal fibroblasts alone (Lin-), indicating a clonal disadvantage to ENFs as compared to all 
other dermal progenitors. Conversely, EPFs increased from ~2% of dermal cells at E14.5 
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(EPF:ENF = 1:33) to ~72% at P0 (EPF:ENF = 4:1) (Fig. 1b-c) and in proportion to all other 
dermal progenitors (Fig. 1c). We then placed ENF and EPF lineages in relation to previously 
described adult mesenchymal cell populations based on the expression of surface markers 
(Supplementary Fig. 1). About 3% of Lin- cells expressed fibro-adipogenic progenitor (FAP) 
markers13-15 (Lin-integrin  7-Sca1+PDGFR +) that were enriched in  EPFs (Supplementary 
Fig. 1c,f,g); while pericyte markers16 (Lin-CD146+) comprised 5% of total Lin- cells and were 
enriched in ENFs (Supplementary Fig. 1d,f,g). Mesenchymal stem cell markers17 (Lin-
CD29+CD105+) were abundant in both ENFs and EPFs (Supplementary Fig. 1e-g). Immuno-
labelling on En1Cre;R26VT2/GK3 (see Methods) neonates sections showed adipocytes (FABP4) 
or pre-adipocytes18 (Dlk1 and Sca1) were more abundant in EPFs (Supplementary Fig 2a-
c). Similarly, the smooth muscle marker  SMA was enriched in EPFs compared to ENFs 
(Supplementary Fig 2d). Immunostaining of reticular and papillary dermis markers (Dlk1, 
TNC, CD26) showed that their expression was not exclusive to either lineage 
(Supplementary Fig 2b,e,f), indicating that EPFs and ENFs do not preferentially allocate to 
either anatomic location. 
To determine if the decline in ENFs numbers is due to programed cell death or a decrease 
in proliferation, we performed TUNEL staining and immuno-labelling of cleaved Caspase 3 
(Cas3) and the proliferation marker Ki67 on sections of E14.5, E16.5 and E18.5 
En1Cre;R26mTmG embryos. ENFs underwent significantly more apoptosis than EPFs at E14.5 
and E16.5 (Fig 1e-f). Conversely, the number of proliferating EPFs steadily increased from 
E14.5 to E18.5 while ENF proliferation significantly decreased (Fig 1d, f). Together, our 
results show that the decay in ENF population is primarily due to a clonal disadvantage. 
To study the clonal dynamics of ENF-to-EPF replacements in situ at single cell levels, we 
used a transgenic ‘Rainbow’ reporter system (En1Cre;R26VT2/GK3)19. From the moment of 
En1 expression, individual EPF progenitors were genetically marked with one out of three 
alternate fluorescent colours (YFP, RFP, CFP), while ENFs express GFP. EPF progenitors 
were absent in dermis at E9.5 and first appeared at E10.5 (Fig 2a-d). Coronal sections at 
E10.5 showed that single EPFs and mono-clones developed in close association with 
ectoderm and then extend from the most anterior regions (neck level) down to half of the 
trunk (Fig 2b-c). EPFs remained absent in most posterior regions (including hindlimbs) at 
this stage. At E11.5 EPFs formed two parallel mid-lateral lines that cover the entire back (Fig 
2e). 3D reconstruction of E12.5 embryos showed that EPFs arrange themselves in an arc 
across the back-skin, with migration ‘protrusions’ at anterior sites (Fig 2f and Video 1). 
We next performed immuno-labelling of ECM proteins on histological sections of 
En1Cre;R26VT2/GK3 early developing dermis. Unexpectedly, we found that ENFs deposited 
Fibronectin fibres, but not Collagen I & Collagen III (Fig 2g), indicating that ENFs generate 
a provisional matrix. At anterior sites, Collagen I & Collagen III fibres were visible within the 
dermal matrix in association with EPF clones, indicating EPFs form a ‘mature’ dermis 
(Fig 2h-i). Indeed, at later stages, Collagen I expression was associated with EPFs 
(Supplementary Fig 3). To view the dynamics of ENF-to-EPF replacement, we performed 
live 3D confocal imaging, of the developing back-skin of En1Cre;R26mTmG embryos (E12.5), 
at the anterior margin of the EPF arc (Supplementary Fig 4). We found that the ENF 
cytological structure is displaced to create open gaps into which EPFs migrated (Fig 2j, 
Supplementary Fig 4, and Video 2). EPFs colonized the provisional dermis, through both 
dorsal and lateral trajectories (Fig 2j arrows). This local dynamic displacement of ENF-to-
EPF cytological structures was completed within 24 hours.  
We then analysed the migration behaviours of single cells in three-dimension by 
automatically tracking the migration paths of EPFs at 15min intervals. We obtained 144 high-
quality tracks of fibroblasts across an area of ~170 µm2 and ~100 µm deep (Fig 3a). From 
a coronal plane of view, we observed characteristic reticular patterns wherein EPFs follow 
seemingly collective behaviours (Fig 3b). The EPFs migrated in vertical columns along the 
dorsal-ventral axis (Fig 3c-d). Anterior tracks had more dispersed points along the dorsal-
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ventral axis than posterior tracks, indicating that anterior EPFs migrated faster than posterior 
EPFs (Fig 3e-f).  
Unexpectedly, EPFs migrated ununiformly, and in three distinctive ways: (1) “converging” 
migration to a fixed space (Fig 3b), (2) “localized” migration where EPFs move in a limited 
space without directly contacting each other (Fig 3g), or (3) “diverging” migration of 
several EPFs from a space unit (Fig 3h). These three migration types occurred in clusters 
of 3-6 fibroblasts that shared common behaviours. Sequences of several units with varied 
migration behaviours could be detected even along a relative short distance of 170 µm, 
indicating that EPF movements in situ are directed locally, by micro-environmental cues. 
These observations are in contrast to observations from fibroblast migration assays in two-
dimension, and demonstrate that EPFs exhibit intricate migration repertoires in vivo.  
 
Dermal lattice development follows Engrailed-1 lineage replacement 
Having documented the cellular conversion from ENFs to EPFs, we went on to describe 
dermal lattice development. Since dermal structure is too complex to be analysed with 
simple Euclidean geometry parameters, we turned to fractal analysis to measure the 
complexity of cellular and ECM fiber arrangements. In this analysis, the fractal dimensions 
(FD) and lacunarity (L) values quantitatively assess the complexity and porosity of 2D 
shapes (Supplementary Fig. 5a). The complex arrangements (e.g. blood vessels and 
tumors20-22) score higher FD values than simpler arrangements (e.g. geometrical shapes). 
Porous structures (e.g. sponges) score higher L values than smooth surfaces (eg. scales).  
We first resolved the cellular organization during dermal morphogenesis using histological 
sections of En1Cre;R26VT2/GK3 embryos. Early (E11.5-12.5) ENF regions were smoother and 
more complex, while later stages (E14.5-E16.5) became simpler and more porous 
(Supplementary Fig 5b-c). This indicates a drift from a compact mesenchymal arrangement 
to a more interspaced cellular organization of a mature dermis. Anterior ENF arrangements 
at E12.5 were more complex and smoother than posterior cells (Supplementary Fig. 5c), 
indicating that, at E12.5, anterior and posterior regions have different cellular organizations. 
Conversely, EPFs underwent two major cellular rearrangements during development: 1) 
Early EPFs (E10.5-11.5) cluster tightly in complex patterns with individual cells having 
smooth shapes, 2). After E12.5 these clusters split into individual cells with increasing 
complex arrangements (Fig. 4a-b). At E12.5 anterior EPFs decreased in FD value, while 
posterior EPFs retained similar complexity to their earlier stage. 3D rendered pictures of 
single EPFs revealed that posterior EPFs were morphologically simpler than anterior EPFs 
(Fig. 4c). A sudden increase in complexity of anterior EPFs in E12.5 embryos correlated in 
time with the migration of EPFs (Fig. 2f, j, Fig. 3, Supplementary Fig. 4, and Video 1-2), 
suggesting that changes in EPF morphology cause or are caused by migrations. Together, 
our fractal analysis characterizes dynamic spatiotemporal changes in dermal lattice 
development, and link dermal maturation steps to distinct embryonic fibroblastic lineages. 
To determine if dermal lattice organization is changed following EPF’s expansion, we 
analysed matrix fibre alignment at different stages in dermal regions that do or do not contain 
EPFs. Since Collagen precludes the earlier stages of development where EPFs initially seed 
the back-skin, we used Fibronectin to study the patterns of dermal lattice development. The 
distance between fibres increased progressively from E11.5 to E16.5 (Fig. 4d and 
Supplementary Fig. 6), concurrent with EPF development. At the same time there was a 
progressive decrease in complexity and an increase in porosity (Fig. 4e-f). This 
demonstrates that a gradual transformation of the dermal Fibronectin matrix occurs, from a 
relaxed and disorganized framework towards a more stretched conformation (Fig. 4g). Our 
fractal analysis of EPF’s cellular arrangements stresses that E12.5 is a pivotal time-point 
when anterior regions are actively changing while posterior regions are still dormant. The 
co-occurrence of Fibronectin framework transformation and EPF morphological changes 
links ECM arrangements with distinct cell migration behaviours during development. To 
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directly prove this link, we used an inducible-Cre labelling system to follow single fibroblastic 
cells (either ENFs or EPFs) and their sibling cells during back-skin development, and 
compared behaviours between anterior and posterior sites. Fibroblastic clone size increased 
and clone expansion extended across the dorsal-ventral axis in the most anterior locations; 
while singly labelled cells and small clones remained close to the ectoderm in posterior 
regions (Fig. 4h-i). These experiments show that the dynamics of structure changes across 
the anterior-posterior dermal axis influence both the cell division rate of fibroblastic 
precursors and the migration trajectories of their clonal colonies.  
Next we aimed to detect in more detail discrete cellular arrangements at later stages, when 
fibroblast clones are too widespread and intermixed. We generated a tissue-level description 
of dermal cellular organization by calculating local FD and L values from E16.5 
En1Cre;R26VT2/GK3 embryos. Low-power images showed that more compact tissues such as 
epidermis, hypodermis, muscle and cartilage had higher FD values than dermis 
(Supplementary Fig. 5d-e), indicating the validity of the fractal analysis. From the high-power 
images, we could identify five distinct dermal layers (DL-1-5) organized in parallel sheets 
across the back-skin (Fig. 4j-n). DL-1 and DL-5 were in direct contact with the epidermis and 
hypodermis respectively, were more complex and smoother, and were composed of densely 
packed EPFs (~85% and ~75%). DL-2 and DL-4 were simpler and porous, were composed 
predominantly of EPFs (~75% and ~90%). DL-3 was complex and porous and was 
composed primarily of elongated ENFs (~75%). The cellular organization of the dermis at 
E16.5 therefore has a mirrored pattern with outer flanking dense dermal layers in direct 
contact with the epidermis and hypodermis, and two intermediate porous layers, separated 
by a middle layer devoid of EPFs. Critically, within each internal layer there are micro-
domains with distinct complexity values across the anterior-posterior axes. Tissue structure 
complexity and porosity does not vary linearly across these micro-domains. In fact, in 
several places the deep dermis is abruptly interspersed with distinct cellular arrangements 
(Fig. 4j right panels), which might result from local migration patterns at earlier stages of 
development. 
 
Scarring transition follows an anterior-to-posterior sequence 
We showed above that EPFs increase within the back-skin from an anterior to posterior 
sequence. We previously showed that adult EPFs produce scars11. We therefore speculated 
that the fetal regeneration-to-scar transition is linked to engrailed lineage replacement and 
could be due to the gradual increase in EPF abundance during dermal development. If this 
is correct, we would expect that wounds inflicted at early fetal stages would regenerate from 
ENFs, and that the transition from regeneration-to-scarring would take on an anterior to 
posterior sequence. 
To test our 1st hypothesis, we generated wounds in the back-skin of En1Cre;R26mTmG E12.5 
embryos and analysed both lineage compositions and ECM depositions (Fig. 5a). At 48 
hours post-wounding, ENFs had migrated into wound beds, where a provisional Fibronectin-
rich matrix had been generated, virtually absent of EPFs or Collagen I fibres (Fig. 5b-c). 
Fractal analysis of fetal wounds indicated that lattice arrangement at the injury site was not 
different from that of the adjacent fetal skin (Fig. 5d-f). Thus, during fetal skin regeneration, 
ENFs sculpt the wound bed matrix without the intervention of EPFs.  
To test our 2nd hypothesis, we cultured skin biopsies from different anterior-posterior regions 
of E19.5 WT embryos (Fig. 5g). Anterior biopsies deposited significantly more Collagen-rich 
scars (Fig. 5h right panel) than posterior biopsies (Fig. 5h left panel). Fractal analysis 
revealed that posterior matrix was significantly simpler than anterior one (Fig. 5i), suggesting 
that at this stage anterior fibroblasts are more fitted to create a scar than posterior fibroblasts. 
Collectively, these experiments demonstrate that the fetal regeneration-to-scar transition 




Engrailed-1 lineage replacement drives regeneration-to-scar transition  
We next asked whether EPFs from early stages possess scarring capacities or if, 
alternatively, they undergo a developmental maturation, whereby they acquire scar-
producing abilities, over time. To test this idea, we purified EPFs from the back-skin of 
En1Cre;R26mTmG embryos/neonates at regenerating (E16.5) or scarring (P1) stages and 
intradermally transplanted them in equal number (2x105) around the edges of fresh splinted 
wounds on the back-skin of adult immuno-deficient (Rag2-/-) mice. We then assessed the 
contribution of EPFs from different ages to scar formation 14 days after 
transplantation/wounding (Fig. 6a). Transplanted EPFs from P1 that migrated into the 
wounds, deposited Collagen I extensively within host wound beds (Fig. 6b). Some EPFs 
deposited ectopic Collagen I at their original transplanted location (Fig. 6c). Strikingly, 
transplanted EPFs from E16.5 embryos had the same scarring capacities as P1 EPFs, 
depositing Collagen I both within wounds and at ectopic uninjured sites (Fig. 6d-e). EPFs 
from both E16.5 and P1 had pathologically active cell morphologies, with membrane 
protrusions that span across and intermingle with the Collagen I fibres (Fig. 6e’). Fractal 
analysis showed that Collagen I arrangements were more complex and smoother in EPF-
transplanted regions (day 14 post-wounding) and in adult scars (day 21 post-wounding), 
while simpler and more porous in non-injured adult and fetal dermis (Fig 6f). Our results 
demonstrate that fetal EPFs are capable of producing and organizing a scar tissue, just as 
well as newborn EPFs, and that the absence of scar-formation in early fetal skin is due to 
scarcity of EPFs, rather than their developmental immaturity. Together, the mechanism 
behind the dynamic transition from regeneration to scarring in fetus is En1 lineage 
replacement during back-skin development. 
 
ENFs or native lattice reduce scarring in adult wounds 
Since we found that ENF abundance in dermis was associated with regenerative outcomes 
at early stages, and since we also showed that ENFs sculpted a provisional lattice during 
development, we asked whether transplantation of ENFs alone would regenerate adult 
dermal wounds. To test this hypothesis, we transplanted fetal (E16.5) ENFs into back-skin 
wounds of adult Rag2-/- mice and allowed wounds to heal for 14 days (Fig. 7a). As expected, 
sites of ENF transplantations had a more reticular lattice arrangement, compared to fibrotic 
lattice arrangements at sites of EPF transplantations (Fig. 7b-c). Fractal analysis indicated 
that ENF transplantation sites were significantly simpler and more porous in lattice 
arrangements, compared to EPF-transplanted sites or to mock-transplanted control wounds 
(Fig. 7d). In line with the reduction of scarring severity, immune-labelling of an endothelial 
marker CD31 showed a significantly higher infiltration of blood vessels into the wound beds 
at sites of ENF transplantations, as compared to EPF- or mock-transplanted wounds (Fig. 
7e-i). Many of the transplanted ENFs were closely associated with blood vessels, which 
were interlaced with one another to generate vascular networks within the transplanted sites 
(Fig. 7g).  
To test if the ENF-generated lattice itself promotes a regenerative outcome, we transplanted 
de-cellularized back-skin from P5 WT mice into back-skin wounds of Rag2-/- mice (Fig. 7j). 
10 days later, we found that fibroblasts in the control wounds and in the borders between 
the wound and the transplanted matrix had a typical active morphology with membrane 
protrusions (Fig. 7k-l). Conversely, resident cells within the transplanted matrix had an 
inactive morphology with round cytoplasm (Fig. 7m). Immuno-labelling of  SMA revealed 
the activated fibroblasts were present in the control wound beds and in the matrix-wound 
border (Fig. 7n-o), and mostly devoid from transplanted matrix (Fig. 7p). These experiments 
show that a ‘healthy’ dermal lattice can be imposed, locally, in two ways. First, 
transplanting ENFs expands the existing pool of resident ENFs, and allows ENFs to sculpt 
a provisional matrix. Alternatively, transplantations of de-cellularized dermal lattice, in 
essence, mimic dermal development, and in the presence of which EPFs do not promote a 
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pathologic scar. Both approaches, if they could be made industrially, provide therapeutic 
possibilities for a range of dermal pathologies, including patients suffering from large skin 
burns or wounds. 
 
Discussion 
We have previously shown11 that EPFs are the primary cells responsible for fibrotic 
outcomes in adult settings of wound healing, irradiation fibrosis and melanoma cancer 
growth. Here, we find that ENFs, not EPFs, are the primary sculptors that drive dermal lattice 
development and its regeneration in fetal wound healing settings. We show that transplanted 
fetal ENFs/EPFs into adult wounds impose regenerative vs. scarring outcomes, respectively, 
and that the phenotypic shift in dermal response to injury (from regeneration to scarring) is 
driven by Engrailed-1 lineage replacement (Supplementary Figure 7).  
Using in vivo live imaging, we disclose 3 distinct migration patterns of dermal fibroblasts 
during back-skin development: localized, diverging or converging migrations. To our 
knowledge, these migration patterns have never been described in 2D or 3D assays to date. 
We hypothesize that each of the three migration patterns establishes distinct dermal 
architectures that collectively drive the remarkable architectural complexity that we observe 
during dermal development. Diverging migration patterns could indicate fibroblastic cell 
invasiveness, while converging migrations indicates collective and interconnected 
behaviours as opposed to individualistic. Since fibroblastic migrations impinge on collagen 
bundle alignments, we expect these individual migration patterns, through their distinct 
molecular programs, to influence scar tissue severity, as well as fibroblastic invasiveness 
into tumours.  
Our findings have additional developmental, evolutionary and clinical implications outlined 
below. 
Other groups have recently implicated separate fibroblastic lineages in the differentiation of 
the back-skin epidermis18,23-24. Fetal processes of epidermal development, hair follicle and 
sebaceous gland differentiation, may require specialized stromal signals and cells. The 
priority for adults is a quick fix of breached skin, which likely requires different stromal signals 
and cells to produce a scar. These two diverged requirements at different stages of fetal life 
are maintained through dynamic cellular shuffling of fibroblastic populations, allowing 
specialized types of fibroblasts to accommodate specific fetal and adult requirements.  
We demonstrate here that the ENF-to-EPF switch in dermis imposes the phenotypic 
transition from regeneration to scarring in response to injury. In evolutionary terms this 
switch provides a model to explain how dermal regeneration was retained in some adult 
rodent species such as African spiny mice25. We speculate that such species have retained 
the fibroblastic cell compositions of fetal stage dermis (ENFs>EPFs), and have resisted the 
ENF-to-EPF lineage successions.  
We describe, and map in detail, here a mechanism for the general acquisition of scarring 
ability in the skin. We believe both the temporal- and spatial-dynamics of EPFs, the 
determinants of scarring, will be widely clinically applicable. Consideration of lineages with 
engrailed history will outline a favourable time window for surgeons to work in, when scarring 
outcomes will be predicted to be at a bare minimum, such as during corrective surgery for 
Spina bifida, or equally, it could be applicable to the removal of paediatric malignancies. 
Our findings also carry implications for adult scarring. There are no definitive strategies to 
prevent scar formation, and current clinical practice is focused on scar acceptance rather 
than its amelioration. We have demonstrated two separate strategies that reduce scar 
outcomes in adult injured skin. Both ENF transplantation and de-cellularized dermis 
transplantation assays provide a proof-of-concept for a therapeutic option that could be used 
to treat large wounds, scolds or burns.  
Our findings also create opportunities for the intense field of bio-engineered autologous 
dermo-epidermal human skin grafts that are currently being tested in Phase I and II clinical 
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studies. Skin grafts include all fibroblastic lineages within dermis and are therefore likely to 
produce scars upon transplantation. We predict it would be advantageous to graft pure 
human ENFs or ENFs combined with dermo-epidermal skin. In essence, this dermal milieu 
would override the ENF-to-EPF population shift and favour regeneration over scarring. 
In sum, we use single cell clonal analysis, 3D imaging, computational cell tracking and in 
silico analysis, to follow the behaviours of fibroblast lineages in vivo. We document fibroblast 
lineage specific proliferations, migrations and secretions, and demonstrate how such a 
fundamental process as dermal morphogenesis actually occurs. Our finding of Engrailed-1 
lineage replacement links dermal morphogenesis with the phenotypic shift in response to 
dermal injury. We believe our findings open up previously unrecognised opportunities for 





Statistical reports for Fig. 1, 4, 5, and 7 and Supplementary Fig. 3 and 5, have been provided 
as Supplementary Table 1. All other data supporting the findings of this study are available 
from the corresponding author on reasonable request. 
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Figure 1 EPFs replace ENFs during mouse back-skin development. a, Genetic labeling 
systems used ‘color-code’ cells. b, Representative flow cytometry plots of ENFs/EPFs from 
En1Cre;R26mTmG embryos at different developmental stages. All Cre+ embryos (ranging from 
3-6 embryos) from an entire litter were pooled together for a single analysis. GFP intensity 
(X-axis) is plotted against RFP intensity (Y-axis). c, EPFs/ENFs percentages of Lin- (lines), 
or total live cells (dashed lines). d,e, Representative immunofluorescence images of Ki67 
(d) or Cas3 (e) in E18.5 En1Cre;R26mTmG embryos, arrows indicate Ki67 or Cas3 positive 
cells, Scales: 50 µm. f, EPFs/ENFs positive for Ki67, Cas3, or TUNEL. n = optical fields 
analysed from sections of three E14.5 embryos, two E16.5 embryos and one E18.5 embryo 
stained for Ki67 (n = 24, 28 and 16, respectively), Cas3 (n = 20, 15 and 14, respectively), 
TUNEL (n = 9, 28 and 7, respectively). Mean ± SEM. ANOVA, Tukey test, *p<0.05, **p<0.01, 
***p<0.001. Additional adjusted p values are listed in Supplementary Table 1.  
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back-skin. Dermal fibroblast  were mo tly ENFs arly on and their 
numbers declined slowly during subsequent development, followed 
by a steep decline between embryonic day 14.5 (E14.5) and E18.5 
(~90% down to ~20%; Fig. 1b,c). The drop in ENF numbers was pro-
portional to total dermal cells (including haema opoietic, endothe-
lial and lymphatic) and to dermal fibroblasts alone (Lin!), indicating 
a clonal disadvantage to ENFs compared to all other dermal pro-
genitors. Conversely, EPF numbers increased from ~2% of dermal 
cells at E14.5 (EPF/ENF ratio = 1/33) to ~72% at postnatal day 0 (P0) 
(EPF/ENF ratio = 4/1) (Fig. 1b,c) and in proportion to all other der-
mal progenitors (Fig. 1c). We then placed ENF and EPF lineages in 
relation to previously described adult mesenchymal cell populations 
based on the expression of surface markers (Supplementary Fig. 1). 
About 3% of Lin! cells expressed fibro/adipogenic progenitor (FAP) 
markers13–15 (Lin–integrin " 7–Sca1+PDGFR" +) that were enriched 
in EPFs (Supplementary Fig. 1c,f,g), whereas pericyte markers16 
(Lin!CD146+) comprised 5% of total Lin! cells and were enriched 
in ENFs (Supplementary Fig. 1d,f,g). Mesenchymal stem cell mark-
ers17 (Lin!CD29+CD105+) were abundant in both ENFs and EPFs 
(Supplementary Fig. 1e–g). Immunolabelling on En1Cre;R26VT2/GK3  
(see Methods) neonate sections showed that adipocytes (fatty acid-
binding protein 4 (FABP4)) or preadipocytes18 (proten delta homo-
logue 1 (Dlk1) and stem cells antigen 1 (Sca1)) were more abundant 
in EPFs (Supplementary Fig. 2a–c). Similarly, the smooth muscle 
marker " -smooth muscle actin (" -SMA) was enriched in EPFs 
compared to ENFs (Supplementary Fig. 2d). Immunostaining of 
reticular and papillary dermis markers (Dlk1, tenascin-C (TNC) 
and CD26) showed that their expression was not exclusive to either 
lineage (Supplementary Fig. 2b,e,f), indicating that EPFs and ENFs 
do not preferentially allocate to either anatomical location.
To determine whether the decline in ENF numbers is due to pro-
grammed cell death or a decrease in proliferation, we performed 
TdT-mediated dUTP nick end labelling (TUNEL) staining and 
immunolabelling of cleaved caspase 3 (Cas3) and the proliferation 
mark r Ki67 on sections of E14.5, E16.5 and E18.5 En1Cre;R26mTmG 
embryos. ENFs underwent significantly more apoptosis than EPFs 
at E14.5 and E16.5 (Fig. 1e,f). Conversely, the number of proliferat-
ing EPFs steadily increased from E14.5 to E18.5, whereas ENF pro-
liferation significantly decreased (Fig. 1d,f). Together, our results 
show that the decay in the ENF population is primarily due to a 
clonal disadvantage.
To study the clonal dynamics of ENF-to-EPF replacements in 
situ at single-cell levels, we used a transgenic ‘Rainbow’ reporter 
system (En1Cre;R26VT2/GK3)19. From the moment of En1 expression, 
individual EPF progenitors were genetically marked with one out 
of three alternate fluorescent colours (yellow fluorescent protein 
(YFP), RFP or cyan fluorescent protein (CFP)), whereas ENFs 
expressed GFP. EPF progenitors were absent in the dermis at E9.5 
and first appeared at E10.5 (Fig. 2a–d). Coronal sections at E10.5 
showed that single EPFs and monoclones developed in close asso-
ciation with the ectoderm and then extend from the most anterior 
regions (neck level) down to half of the trunk (Fig. 2b,c). EPFs 
remained absent in most posterior regions (including hindlimbs) 
at this stage. At E11.5, EPFs formed two parallel mid-lateral lines 
that covered the entire back (Fig. 2e). 3D reconstruction of E12.5 
embryos showed that EPFs arrange themselves in an arc across the 
back-skin, with migration ‘protrusions’ at anterior sites (Fig. 2f and 
Supplementary Video 1).
We next performed immunolabelling of ECM proteins on his-





























































































































































































Fig. 1 | EPFs replace ENFs during mouse back-skin development. a, Genetic-lab lling systems used ‘colour-coded’ cells. b, Representative flow cytometry 
plots of ENFs and EPFs from En1Cre;R26mTmG embryos at different developmental stages. All Cre+ embryos (ranging from 3 to 6 embryos) from an entire litter 
were pooled together for a single analysis. GFP intensity (x!axis) is plotted against RFP intensity (y!axis). c, EPFs and ENFs percentages of Lin–  
(solid lines) or total live cells (dashed lines). d,e, Representative immunofluorescence images of Ki67 (d) or Cas3 (e) in E18.5 En1Cre;R26mTmG embryos; 
arrows indicate Ki67-positive or Cas3-positiv  cells, respectively. Scale bars, 50!µ m. f, EPFs and ENFs positive for Ki67, Cas3 or TUNEL. n!= !optical fields 
analysed from sections of three E14.5 embryos, two E16.5 embryos and one E18.5 embryo stained for Ki67 (n!= !24, 28 and 16, respectively), Cas3 (n!= !20, 
15 and 14, respectively) and TUNEL (n!= !9, 28 and 7, respectively). Mean!± !s.e.m. ANOVA, Tukey test, *P!< !0.05, **P!< !0.01, ***P!< !0.001. Additional 
adjusted P values are listed in Supplementary Table 1.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.




Figure 2 EPFs direct dermis development. a-e, Coronal sections of E9.5-E11.5 
En1Cre;R26VT2/GK3 embryos. Arrows indicate single EPFs (b, d). Dashed line indicates 
ectoderm border (b). Dotted lines delimitate EPFs clones (c-e). f, E12.5 En1Cre;R26VT2/GK3 
embryo showing EPFs arc across the back skin. f’,f’’, high magnification from boxes in f. 
Arrows indicate migrating EPFs. Cross indicate embryonic axes. g-i, Immunofluorescences 
for Fibronectin (g), Collagen I (h), or Collagen III (i) in coronal section of E9.5 or E11.5 
En1Cre;R26VT2/GK3 embryos. Doted lines delimitate EPFs. j, Orthogonal view from time-lapse 
images (0 h and 24 h) from the anterior region of E12.5 En1Cre;R26mTmG embryo. Dotted 
lines in X-Y frame delimitate the EPF-induced ENF gap. Green channel (EPFs) was omitted 
in X-Y frames for clarity. Dotted lines from X-Z and Y-Z delimitate EPFs. Dashed lines mark 
the dorsal surface. Arrows indicate EPFs movement direction. Scales: a-d = 50 µm, e-f = 
500 µm, f’-f’’-g-i = 200 µm, j = 100 µm. ec = ectoderm, Ant = anterior, Pos = posterior, D = 
dorsal, V = ventral. Images in a-j are representative of three experiments. 
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Unexpectedly, we foun  that ENFs deposited fibrone tin fibres, but 
not collagen I and collagen III (Fig. 2g), indicating that ENFs gen-
erate a provisional matrix. At anterior sites, collagen I and collagen 
III fibres were visible within the dermal matrix in association with 
EPF clones, indicating that EPFs form a ‘mature’ dermis (Fig. 2h,i). 
Indeed, at later stages, collagen I expression was associated with 
EPFs (Supplementary Fig 3). To view the dynamics of ENF-to-EPF 
replacement, we performed live 3D confocal imaging of the develop-
ing back-skin of En1Cre;R26mTmG embryos (E12.5) at the anterior mar-
gin of the EPF arc (Supplementary Fig. 4). We found that the ENF 
cytological structure is displaced to create open gaps into which EPFs 
migrated (Fig. 2j, Supplementary Fig. 4 and Supplementary Video 2). 
EPFs colonized the provisional dermis, through both dorsal and lat-
eral trajectories (arrows in Fig. 2j). This local dynamic displacement 
of ENF-to-EPF cytological structures was completed within 24 hours.
We then analysed the migration behaviours of single cells in 3D 
by automatically tracking the migration paths of EPFs at 15-min 
intervals. We obtained 144 high-quality tracks of fibroblasts across 
an area of ~170 µ m2 and ~100-µ m deep (Fig. 3a). From a coronal 
plane of view, we observed characteristic reticular patterns in which 
EPFs follow seemingly collective behaviours (Fig. 3b). The EPFs 
migrated in vertical columns along the dorsal–ventral axis (Fig. 3c,d). 
Anterior t acks had more dispersed points along the dorsal–ventral 
axis than posterior tracks, indicating that anterior EPFs migrated 
faster than posterior EPFs (Fig. 3e,f).
Unexpectedly, EPFs migrated ununiformly and in three dis-
tinctive ways: (1) ‘converging’ migration to a fixed space (Fig. 3b), 
(2) ‘localized’ migration where EPFs move in a limited space without 
directly contacting each other (Fig. 3g) or (3) ‘diverging’ migration 
of several EPFs from a space unit (Fig. 3h). These three migration 
types occurred in clusters of 3–6 fibroblasts that shared common 
behaviours. Sequences of several units with varied migration behav-
iours could be detected even along a relative short distance of 170 µ m, 
indicating that EPF movements in situ are directed locally by micro-
environmental cues. These observations are in contrast to observa-
tions from fibroblast migration assays in 2D and demonstrate that 
EPFs exhibit intricate migration repertoires in vivo.
Dermal lattice development follows En1 lineage replacement. 
Having documented the cellular conversion from ENFs to EPFs, 
E9.5a
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g h i j



























Fig. 2 | EPFs direct dermis development. a–e, Coronal sections of E9.5–E11.5 En1Cre;R26VT2/GK3 embryos. Arrows indicate single EPFs (b,d). Dashed line 
indicates the ectoderm (ec) border (b). Dotted lines delimitate EPFs clones (c–e). f, E12.5 En1Cre;R26VT2/GK3 embryo showing that EPFs arc across the back-
skin. f’ and f” indicate high magnification from boxes in f. Arrows indicate migrating EPFs. The cross indicates the embryonic axes. Ant, anterior; D, dorsal; 
Pos, posterior; V, ventral. g–i, Immunofluorescence for fibronectin (g), collagen I (h) or collagen III (i) in coronal sections of E9.5 or E11.5 En1Cre;R26VT2/GK3  
embryos. Dotted lines delimitate EPFs. j, Orthogonal view from time-lapse images (0!h and 24!h) from the anterior region of an E12.5 En1Cre;R26mTmG 
embryo. Dotted lines in the x–y frame delimitate the EPF-induced ENF gap. The green channel (EPFs) was omitted in x–y frames for clarity. Dotted lines 
from x–z and y–z delimitate EPFs. Dashed lines mark the dorsal surface. Arrows indicate the movement direction of EPFs. Scale bars, 50!µ m (a–d), 500!µ m 
(e,f), 200!µ m (f',f'',g–i) and 100!µ m (j). Images in a–j are representative of three experiments.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.




Figure 3 EPFs exhibit three migration behaviours in vivo. a, 4D scatter plot of individual 
tracks, the colour ramp indicates time (Blue = first; Red = last time point). b, Top X-Y view 
showing the reticular patterns of migration. Dashed lines in zoomed view (right panel) 
delimitate “converging” track points. c, d, Lateral Y-Z views of posterior (c) or anterior (d) 
tracks split in dorsal (up) and ventral (down) regions. e, f, Frontal X-Z views of posterior (e) 
or anterior (f) tracks. g, h, Amplified view of single tracks showing “localized” (g) or 
“diverging” (h) migrations. Colour ramps of tracks of no interest (g, h) were changed to grey-
scale for clarity. Axes units = µm. The 144 cell tracks were derived from one representative 
video.   
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we went on to describe dermal lattice development. As the der-
mal structure is too complex to be analysed with simple Euclidean 
geometry parameters, we turned to fractal analysis to measure 
the complexity of cellular and ECM fibre arrangements. In this 
analysis, the fractal dimensions (FD) and lacunarity (L) values 
quantitatively assess the complexity and porosity of 2D shapes 
(Supplementary Fig. 5a). The complex arrangements (for example, 
blood vessels and tumours20–22) score higher FD values than simpler 
arrangements (for example, geometrical shapes). Porous structures 
(for example, sponges) score higher L values than smooth surfaces 
(for example, scales).
We first resolved the cellular organization during dermal mor-
phogenesis using histological sections of En1Cre;R26VT2/GK3 embryos. 
Early (E11.5–E12.5) ENF regions were smoother and more com-
plex, whereas later stages (E14.5–E16.5) became simpler and more 
porous (Supplementary Fig. 5b,c). This indicates a drift from a 
compact mesenchymal arrangement to a more interspaced cellu-

















































































Fig. 3 | EPFs exhibit three migration behaviours in vivo. a, 4D scatter plot of individual tracks; the colour ramp indicates time (blue, first time point; red, 
last time point). b, Top x–y view showing the reticular patterns of migration. Dashed lines in the zoomed view (right panel) delimitate 'converging' track 
points. c,d, Lateral y–z views of posterior (c) or anterior (d) tracks spli  into dorsal (up) and ventral (down) regions. e,f, Frontal x–z views of posterior (e) or 
anterior (f) tracks. g,h, Amplified view of single tracks showing 'localized' (g) or 'diverging' (h) migrations. Colour ramps of tracks of no interest (g,h) were 
changed to greyscale for clarity. Axes units, µ m. The 144 cell tracks were derived from one representative video.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.




Figure 4 Dermal lattice is actively changing during development. a, b, Fractal 
dimension (a) and lacunarity (b) values derived from confocal images of EPFs from different 
regions and developmental stages. Mean ± SEM. RM ANOVA, Newman-Keuls test, n = 9 
optical fields of anterior or posterior regions at E11.5, E12.5, E14.5, E16.5, respectively. 
*p<0.05, **p<0.01, ***p<0.001. c, 3D reconstructions of posterior (up) and anterior (down) 
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Fig. 4 | Dermal lattice is actively changing during development. a,b, Fractal dimension (FD) values (a) and lacunarity (L) values (b) derived from images 
of EPFs from different regions and developmental stages. Mean!± !s.e.m. Repeated measures ANOVA, Newman–Keuls test, n!= !9 optical fields of anterior or 
posterior regions at E11.5, E12.5, E14.5 and E16.5. *P!< !0.05, **P!< !0.01 and ***P!< !0.001. c, 3D reconstructions of posterior and anterior En1Cre;R26VT2/GK3  
EPFs. d, Distances (µ m) between fibronectin fibres calculated from linear profiles of three confocal images of fibronectin-immunolabelled sections 
(Supplementary Fig. 6; n!= !184 (E11.5 anterior), 138 (E11.5 posterior), 135 (E12.5 anterior), 155 (E12.5 posterior), 98 (E14.5 anterior), 105 (E14.5 posterior), 
91 (E16.5 anterior), 128 (E16.5 posterior) measurements), mean!± !s.e.m., ANOVA, Holm–Sidak test, *P!< !0.05. e,f, FD values (e) and L!values (f) derived 
from fibronectin stainings from different regions and developmental stages. Mean!± !s.e.m. Repeated measures ANOVA, Newman–Keuls test, n!= !3 
optical fields of anterior or posterior regions at E11.5, E12.5, E14.5 and E16.5. *P!< !0.05, **P!< !0.01 and ***P!< !0.001. g, Fibronectin matrix changes from 
a relaxed framework to a rigid matrix. h, FSP1 expression in anterior (left) or posterior (right) regions of E12.5 ActinCre-ER;R26VT2/GK3 embryos after 24!h of 
1!nM 4-hydroxytamoxifen exposure. Dotted lines delimitate single clones. i, Percentage of labelled cells in clones from two independent embryos. j, Local 
(subsampled) fractal analysis of a E16.5 En1Cre;R26VT2/GK3 dermis. Dashed lines delimitate dermal layers. k, Percentages!± !s.e.m. of EPFs and ENFs in each 
layer; n!= !3 optical fields. Two-way ANOVA, *P!< !0.05, Tukey test. l, Mean!± !s.e.m. number of cells per 1,000!µ m2 of each layer; n!= !3 optical fields.  
One-way ANOVA, *P!< !0.05, Tukey test. m,n, FD values (m) and L values (n) derived from different dermal layers; n for FD and L, respectively!= !58 and 58 
(epidermis), 65 and 65 (DL-1), 198 and 199 (DL-2), 62 and 62 (DL-3), 274 and 281 (DL-4), 92 and 92 (DL-5), and 87 and 91 (hypodermis) subsampled 
values pooled from 3 confocal images. Box and whiskers plots with minimum, lower quartile, median, upper quartile and maximum. One-way ANOVA, 
*P!< !0.05, Tukey test. Scale bars, 20!µ m (c), 200!µ m (h) and 50!µ m (j). P values are listed in Supplementary Table 1.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
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En1Cre;R26VT2/GK3 EPFs. d, Distances in µm between fibronectin fibres calculated from linear 
profiles of three confocal images of fibronectin immuno-labelled sections (Supplementary 
figure 6, n = 184 (E11.5 ant), 138 (E11.5 pos), 135 (E12.5 ant), 155 (E12.5 pos), 98 (E14.5 
ant), 105 (E14.5 pos), 91 (E16.5 ant), and 128 (E16.5 pos) measurements), Mean ± SEM. 
ANOVA, Holm-Sidak test, *p<0.05. e, f, Fractal dimension (e) and lacunarity (f) values 
derived from Fibronectin staining of confocal images from different regions and 
developmental stages. Mean ± SEM. RM ANOVA, Newman-Keuls test, n = 3 optical fields 
of anterior or posterior regions at E11.5, E12.5, E14.5, E16.5, respectively. *p<0.05, 
**p<0.01, ***p<0.001. g, Fibronectin matrix changes from a relaxed framework to a rigid 
matrix. h, Fsp1 expression in anterior (left) or posterior (right) regions of E12.5 ActinCre-
ER;R26VT2/GK3 embryos after 24 h of 1 nM 4-Hydroxytamoxifen exposure. Dotted lines 
delimitate single clones. i, Percentage of labelled cells in clones from two independent 
embryos. j, Local (subsampled) fractal analysis of E16.5 En1Cre;R26VT2/GK3 dermis. Dashed 
lines delimitate dermal layers. k, Percentages ± SEM of EPFs/ENFs in each layer, n = 3 
optical fields. Two-way ANOVA, *p<0.05, Tukey test. l, Mean ± SEM number of cells per 
1000 µm2 of each layer, n = 3 optical fields. One-way ANOVA, *p<0.05, Tukey test. m, n, 
Fractal dimension (m) and lacunarity (n) values derived from different dermal layers, n for 
FD and L respectively = 58 and 58 (Epidermis), 65 and 65 (DL-1), 198 and 199 (DL-2), 62 
and 62 (DL-3), 274 and 281 (DL-4), 92 and 92 (DL-5), and 87 and 91 (Hypodermis) 
subsampled values pooled from three confocal images. Box and whiskers plots with 
minimum, lower quartile, median, upper quartile, and maximum. One-way ANOVA, *p<0.05, 
Tukey test. Scales: c = 20 µm, h = 200 µm, j = 50 µm. The exact p values are listed in 





Figure 5 Regeneration-to-scar transition is coupled to EPFs development. a, E12.5 
En1Cre;R26mTmG embryos were collected, wounded on the back-skin, and kept in culture for 
48 h. b, c, Immunofluorescence for Fibronectin (b) or Collagen I (c). Dotted lines delimitate 
lesion site. Arrows indicate EPFs. d, e, Representative immunofluorescence images of 
fibronectin staining at adjacent fetal skin (d) and wounded site (e) at 48 h post-wounding. f, 
Fractal dimension (left) and lacunarity (right) values derived from fibronectin staining at 
adjacent fetal skin (control) and wounded site at 24 h and 48 h after wounding. n = 6 optical 
fields of control skins, and n = 5 optical fields of wounds from two embryos. Mean ± SEM. 
Two-tailed unpaired Student’s t-test. g, Skin biopsies were taken from anterior, middle, and 
posterior regions of E19.5 WT embryos and cultured for 5 days. h, Masson’s trichrome 
stained sections of posterior (left) or anterior (right) biopsies. Arrows indicate the scar-like 
deposition of ECM. i, Fractal dimension (left) and lacunarity (right) values derived from the 
cyan channel of Masson’s trichrome stained biopsies. Anterior n = 11, middle n = 10, and 
posterior n = 9. Mean ± SEM. One-way ANOVA, Tukey test, *p = 0.0436. Scales: 200 µm.  
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at E12.5 were more complex and smoother than posterior cells 
(Supplementary Fig. 5c), indicating that, at E12.5, anterior and pos-
terior regions have different cellular organizations.
Conversely, EPFs underwent two major cellular rearrange-
ments during development: (1) early EPFs (E10.5–E11.5) cluster 
tightly in complex patterns, with individual cells having smooth 
shapes; and (2) after E12.5, these clusters split into individual cells 
with increasing complex arrangements (Fig. 4a,b). At E12.5, ante-
rior EPFs decreased in FD value, whereas posterior EPFs retained 
similar complexity to their earlier stage. 3D-rendered pictures of 
single EPFs revealed that posterior EPFs were morphologically 
simpler than anterior EPFs (Fig. 4c). A sudden increase in com-
plexity of anterior EPFs in E12.5 embryos correlated in time with 
the migration of EPFs (Figs. 2f,j and 3, Supplementary Fig. 4 and 
Supplementary Videos 1 and 2), suggesting that changes in EPF 
morphology cause or are caused by migrations. Together, our fractal 
analysis characterizes dynamic spatiotemporal changes in dermal 
lattice development and link d rmal maturation steps to distinct 
embryonic fibroblastic lineages.
To determine whether dermal lattice organization is changed fol-
lowing the expansion of EPFs, we analysed matrix fibre alignment at 
different stages in dermal regions that do or do not contain EPFs. As 
collagen precludes the earlier stages of development where EPFs ini-
tially seed the back-skin, we used fibronectin to study the patterns of 
dermal lattice development. The distance between fibres increased 
progressively from E11.5 to E16.5 (Fig. 4d and Supplementary 
Fig. 6), concurrent with EPF development. At the same time, there 










































































Fig. 5 | Regeneration-to-scar transition is coupled to EPFs development. a, E12.5 En1Cre;R26mTmG embryos were collected, wounded on the back-skin and kept 
in culture for 48!h. b,c, Immunofluor scence f r fibronectin (b) or collagen I (c). Dotted li es d limitate the lesion site. Arrows indi ate EPFs.  
d,e, Representative immunofluorescence imag s of fibronectin staining at adjacent fetal skin (control) (d) and the wounded sit  (e) at 48!h post-wounding. 
f, FD values (left) and L!values (right) derived from fibronectin staining at adjacent fetal skin (control) and the wounded site at 24!h and 48!h after wounding. 
n!= !6 optical fields of control skins and n!= !5 optical fields of wounds from two embryos. Mean!± !s.e.m. Two-tailed unpaired Student’s t-test. g, Skin biopsies 
were taken from anterior, middle and posterior regions of E19.5 WT embryos and cultured for 5!days. h, Masson’s trichrome-stained sections of posterior 
or anterior biopsies. Arrows indicate the scar-like deposition of the ECM. i, FD values (left) and L!values (right) derived from the cyan channel of Masson’s 
trichrome-stained biopsies. Anterior: n!= !11, middle: n!= !10 and posterior: n!= !9. Mean!± !s.e.m. One-way ANOVA, Tukey test, *P!= !0.0436. Scale bars, 200!µ m.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.




Figure 6 EPFs are a mature scar-matrix-depositing population. a, E16.5 or P1 
En1Cre;R26mTmG EPFs were sorted and transplanted (2x105) into fresh splinted wounds of 
adult Rag2-/- mice and the tissue was collected 14 days later. b-e, Immunofluorescence for 
Collagen I of scars (b, d) or ectopic un-injured sites (c, e) containing transplanted EPFs from 
P1 mice (b-c) or E16.5 embryos (d-e). e’, High magnification image of a Collagen I-attached 
EPF. Dotted line delimitates EPFs cell-body. f, Collagen I FD and L scatter plot of E12.5 
(squares) and adult (circles) normal dermis, adult scars (triangles), and scars derived from 
ARTICLES NATURE CELL BIOLOGY
(Fig. 4e,f). This demonstrates that a gradual transformation of the 
dermal fibronectin matrix occurs, from a relaxed and disorganized 
framework towards a more stretched conformation (Fig. 4g). Our 
fractal analysis of EPF’s cellular arrangements stresses that E12.5 
is a pivotal time-point when anterior regions are actively chang-
ing while posterior regions are still dormant. The co-occurrence 
of fibronectin framework transformation and EPF morphologi-
cal changes links ECM arrangements with distinct cell-migration 
behaviours during development. To directly prove this link, we used 
an inducible-Cre labelling system to follow single fibroblastic cells 
(either ENFs or EPFs) and their sibling cells during back-skin devel-
opment, and compared behaviours between anterior and posterior 
sites. Fibroblastic clone size increased and clone expansion extended 
across the dorsal–ventral axis in the most anterior locations, whereas 
singly labelled cells and small clones remained close to the ectoderm 
in posterior regions (Fig. 4h,i). These experiments show that the 
dynamics of structural changes across the anterior–posterior dermal 
axis influence both the cell division rate of fibroblastic precursors 
and the migration trajectories of their clonal colonies.
Next, we aimed to detect in more detail discrete cellular arrange-
ments at later stages, when fibroblast clones are too widespread and 
intermixed. We generated a tissue-level description of dermal cel-
lular organization by calculating local FD and L values from E16.5 
En1Cre;R26VT2/GK3 embryos. Low-power images showed that more-
compact tissues, such as the epidermis, hypodermis, muscle and 
cartilage, had higher FD values than the dermis (Supplementary 
Fig. 5d,e), indicating the validity of the fractal analysis. From the 
high-power images, we could identify five distinct dermal lay-
ers (DL-1–DL-5) organized in parallel sheets across the back-skin 
(Fig. 4j–n). DL-1 and DL-5 were in direct contact with the epi-
dermis and the hypodermis, respectively, were more complex and 
smoother, and were composed of densely packed EPFs (~85% and 
~75%, respectively). DL-2 and DL-4 were simpler and porous, and 
were composed predominantly of EPFs (~75% and ~90%, respec-
tively). DL-3 was complex and porous and was composed primarily 
of elongated ENFs (~75%). Thus, the cellular organization of the 
dermis at E16.5 has a mirrored pattern with outer flanking dense 
dermal layers that are in direct contact with the epidermis and the 
hypodermis, and two intermediate porous layers, which are sepa-
rated by a middle layer devoid of EPFs. Critically, within each inter-
nal layer there are microdomains with distinct complexity values 
across the anterior–posterior axes. Tissue structure complexity and 
porosity does not vary linearly across these microdomains. In fact, 
in several places, the deep dermis is abruptly interspersed with dis-
tinct cellular arrangements (right panels in Fig. 4j), which might 
result from local migration patterns at earlier stages of development.
Scarring transition follows an anterior-to-posterior sequence. 
We showed above that EPFs increase within the back-skin from an 
anterior-to-posterior sequence. We previously showed that adult 
EPFs produce scars11. Thus, we speculated that the fetal regener-
ation-to-scar transition is linked to engrailed lineage replacement 
and could be due to the gradual increase in EPF abundance during 











































Fig. 6 | EPFs are a mature scar-matrix-depositing population. a, E16.5 or P1 En1Cre;R26mTmG EPFs were sorted and transplanted (2!  !105) into fresh splinted 
wounds of adult Rag2–/– mice (SCID) an  the tissue was coll cted 14!days later. b–e, Immunofluorescence f  collag n I of scars (b,d) or ectopic uninjured 
sites (c,e) containing transplanted EPFs from P1 mice (b,c) or E16.5 embryos (d,e). e’ is a high-magnification image of a collagen I-attached EPF. Dotted 
lines delimitate the cell bodies of EPFs. f, Collag n I FD and L scatter plot of E12.5 and adult normal dermis, adult scars and scars derived from E16.5 EPFs 
transplants. Scale bars, 50!µ m (b–e) and 20!µ m (e'). Images represent one out of three experiments.
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E16.5 EPFs transplants (diamonds). Scales: b-e = 50 µm, e’ = 20 µm. Images represent 1 
out of three experiments. 
 
 
Figure 7 ENFs and ECM transplantations improve scar outcomes. a, E16.5 
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Fig. 7 | ENF and ECM transplantations improve scar outcomes. a, E16.5 En1Cre;R26mTmG EPFs were sorted and transplanted (2!  !105) into fresh splinted 
wounds of adult Rag2–/– mice and the tissue was collected 2!weeks later. b,c, Masson’s trichrome staining of the EPF-transplanted scar (b) and the  
ENF-transplanted scar (c). d, FD values (left) and L!values (right) derived from the cyan channel of Masson’s trichrome-stained sections. Mean!± !s.e.m. 
n!= !11 optical fields of control, n!= !7 optical fields of EPF transplants and n!= !9 optical fields of ENF transplants. One-way ANOVA, *P!< !0.05, Tukey test.  
e–g, Representative immunofluorescence images of CD31 staining on mock-transplant scars (control) (e), EPF-transplant scars (f) or ENF-transplant scars 
(g). h,i, Quantification of CD31 integrated fluorescence density (h) and CD31+ cells per low-power (! 20) image (i) of mock-transplant, EPF-transplant 
and ENF-transplant scars. Mean!± !s.e.m. n!= !4 optical fields of control, n!= !4 optical fields of EPF-transplant scars and n!= !9 optical fields of ENF-transplant 
scars, pooled from two independent experiments. One-way ANOVA, *P!< !0.05, Tukey test. a.u., arbitrary unit. j, Decellularized matrix transplantation 
experiment. Back-skin explants from P5 WT mice were decellularized and transplanted into fresh splinted wounds of adult Rag2–/– mice and the tissue was 
collected 10!days later. k–m, Masson’s trichrome-stained (k–m) or " -SMA-stained and collagen I-stained (n–p) control wounds (k,n), the border between 
the transplanted matrix and the wound (l,o) or within the transplanted matrix (m,p). Scale bars, 50!µ m. Images in panels b,c, e–g and k–p represent one 
out of two experiments. The exact P values are listed in Supplementary Table 1.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
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adult Rag2-/-  mice and the tissue was collected two weeks after. b, c, Masson’s trichrome 
staining of EPFs-transplant scar (b) and ENF-transplant scar (c). d, Fractal dimension (left) 
and lacunarity (right) values derived from the cyan channel of Masson’s trichrome stained 
sections. Mean ± SEM. n = 11 optical fields of control, n = 7 optical fields EPF-transplants, 
and n = 9 optical fields of ENF-transplants. One-way ANOVA, *p<0.05, Tukey test. . e-g, 
Representative immunofluorescence images of CD31 staining on mock-transplant scars (e), 
EPFs-transplant scars (f) or ENFs-transplant scars (g). h-i, Quantification of CD31 
integrated fluorescence density (h) and CD31+ cells per low-power (20x) image (i) of mock-
transplant, EPFs-transplant, and ENFs-transplant scars. Mean ± SEM. n = 4 optical fields 
of control, n = 4 optical fields EPF-transplant, and n = 9 optical fields of ENF-transplant, 
pooled from two independent experiments. One-way ANOVA,  *p<0.05, Tukey test. AU, 
arbitrary unit. j, Decellularized matrix transplantation experiment. Back-skin explants from 
P5 WT mice were decellularized and transplanted into fresh splinted wounds of adult Rag2-
/- mice and the tissue was collected 10 days after. k-m, Masson’s trichrome (k-m) or αSMA 
and Collagen I (n-p) stained control wounds (k, n), border between the transplanted matrix 
and the wound (l, o), or within the transplanted matrix (m, p). Scales: 50 µm. Images in 
panels b,c, e-g and k-p represent 1 out of two experiments. The exact p values are listed in 
Supplementary Table 1.  
 
Supplementary figures, tables, and videos are available online together with the publisher’s 
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In the presenting work my contribution included: 
 
Experimental design, animal experiments, histological preparations, ex vivo cultures, image 
analysis, and manuscript and figure preparation. 
 
In particular: 
a) Fig.1, 2, extended data Fig.3, 4, and 6: Implementation of chimeric skin grafts to study 
the relative contributions of dermis and fascia compartments. 
b) Extended data Fig 1: Complementary model to fate map fascia cells during wound 
healing. 
c) Fig.3 f-j, Fig.4 j-k, extended data Fig.6, 7, and 10: Fascia ECM fate mapping to show 
the quick wound patch process mediated by fascia-derived EPFs. 
Fig.4 a-c, extended data Fig.8: Fascia blocking experiments showing the generation 
of chronic wounds-like phenotype in absence of the fascia influence. 
d) Extended data Fig.9 a-c and f-g: Ex vivo cultures to prove the irrelevance of cell 
proliferation in the ECM mobilization process. 
e) Fig.5 e-g: Expression analysis of the novel marker NOV in murine fascia and scars. 
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Mammals form scars to quickly patch up wounds and ensure survival by an 
incompletely understood mechanism. Here, we discover that skin scars originate 
from prefabricated matrix in the subcutaneous fascia that homes into wounds. Fate 
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mapping and live imaging revealed that fascia fibroblasts rise to the skin surface after 
wounding, dragging their surrounding extracellular jelly-like matrix, including 
embedded blood vessels, macrophages, and peripheral nerves, to form the 
provisional matrix. Genetic ablation of fascia fibroblasts prevented matrix from 
homing into wounds and resulted in poor scars, whereas placing an impermeable film 
beneath the skin, to prevent fascia fibroblasts migrating upwards, led to chronic open 
wounds. Thus, fascia contains a specialised prefabricated kit of sentry fibroblasts, 
embedded within a movable sealant, that preassemble together diverse cell types and 
matrix components needed to heal wounds. Our findings suggest that chronic and 




Mammalian scarring occurs when specialized fibroblasts immigrate into wounds to deposit 
plugs of extracellular matrix1. Abnormal scarring results in either non-healing chronic 
wounds or aggravating fibrosis2-4 which represent a tremendous burden for patients and to 
the global healthcare system. Just in the US, costs related to impaired scarring rise to tens 
of billions of dollars per year5. 
The origin of fibroblasts in wounds remains unclear and so is the mechanism by which they 
act6. Possible sources such as papillary (upper) and reticular (lower) dermal layers7, 
pericytes8, adipocytes9-10, and bone-marrow derived monocytes11 have been suggested. We 
previously demonstrated that all scars in the back-skin derive from a distinct fibroblast 
lineage expressing the Engrailed-1 gene during embryogenesis and we refer to these cells 
as En1-lineage positive fibroblasts (EPFs)12-13. This lineage is present not only in the skin 
but also in the strata underneath, called fascia. 
The fascia is a gelatinous viscoelastic membranous sheet that creates a frictionless gliding 
interface between the skin and the body’s rigid structure below. Murine back-skin fascia 
extends as a single sheet separated from the skin by the Panniculus carnosus (PC) muscle, 
whereas in humans there is no intervening muscle and the fascia consists of several thicker 
sheets that are continuous with the skin. In humans the facia layers incorporate fibroblasts, 
lymphatics, adipose tissue, neurovascular sheets and sensory neurons14-15. 
Here, we explored the fundamental mechanisms of scar formation by using matrix-tracing 
techniques, live-imaging, genetic lineage-tracing and anatomic fate-mapping models. We 
identified the fascia as a major source for wound-native cells including fibroblasts. Strikingly, 
we found that wound provisional matrix originates from prefabricated matrix in the fascia 
that homes into open wounds as a movable sealant dragging along vasculature, immune 




Wound cells rise from fascia 
To trace the origins of cells in wounds, we developed a fate mapping technique by 
transplanting chimeric, skin and fascia, grafts into living animals (Fig. 1a and see ‘Methods’).  
At 14 days post wounding (dpw), 80.04 ± 3.443% of the labeled cells in the wound were 
from fascia origin (Fig. 1b). Fascia-derived cells clogged up the entire wound bordering the 
regenerated epidermis and even the surrounding dermis, making up 35.46 ± 4.938% of the 
total labeled cells within a 0.2 mm radius (Fig. 1b-c). 81.63 ± 12.84 % of the αSMA+ 
myofibroblasts, and strikingly, nerve, endothelial, and macrophages within wounds were all 
predominantly of fascia origin (Fig. 1d-e). Independently, In vivo labeling of the fascia 
showed same results (Extended Data Fig. 1a and ‘Methods’). Labeled cells populated the 
wounds and surrounding dermis at 14 dpw, whereas in uninjured controls labeled cells 
remained in the fascia (Extended Data Fig. 1b). 56.71 ± 9.319 % of fascia-derived cells in 
wounds expressed classical fibroblast markers (Extended Data Fig. 1c). Labeled 
monocytes/macrophages, lymphatics, endothelium and nerves derived from fascia as well 
(Extended Data Fig. 1d). Collectively, our two independent fate mapping approaches 
demonstrate that fascia is a major reservoir of fibroblasts, endothelial, macrophages, and 
peripheral nerves that populate wounds upon injury. 
 
Fascia fibroblasts dictate scar severity 
We then analyzed the scar-forming EPFs across dermal and fascia compartments by using 
a TdTomato to GFP replacement reporter12-13 (En1Cre;R26mTmG, see ‘Methods’). Fibroblasts 
were the predominant fascia cell type (71.1%), while dermis had a significantly lower fraction 
of fibroblasts (56.4%, Extended Data Fig. 2a-b). Within this population, there were two-times 
more EPFs than En1-naïve fibroblasts (ENFs) in the fascia (61.2% and 31.8% respectively). 
Whereas in dermis, there was a six-fold excess of EPFs (83.13% EPFs vs 12.78% ENFs, 
Extended Data Fig. 2c-d). Fascia was also enriched in regenerative cell types such as 
endothelial cells and lymphatics, while macrophages and nerve cells compositions were 
similar in both compartments (Extended Data Fig. 2e). Thus, a higher fibroblast, endothelial, 
and lymphatic cell content and a lower EPF to ENF ratio distinguishes the fascia from dermis. 
Two-photon microscopy revealed that fascia EPFs arrange in monolayers of consecutive 
perpendicular sheets across the dorsal-ventral axis (Extended Data Fig. 2f and Extended 
Data Video 1). EPFs populate the entire back in topographic continuums extending from the 
fascia and traversing the PC (Extended Data Fig. 2g-h and Extended Data Video 2). Regions 
where PC ended or where nerve bundles and blood vessels traversed it showed also 
continuums of EPFs without clear boundaries (Extended Data Fig. 2i-j). To test if fascia EPFs 
could access dermal layers upon injury, we generated superficial excisional wounds. 
Aggregates of EPFs rising into open wounds from fissures in the PC were observed after 
only 3 dpw (Extended Data Fig. 2k and Extended Data Video 3). Collectively, our observation 
suggests that fascia EPFs easily traverse upwards into dermal layers during wounding and 
are unobstructed by the PC muscle. 
The deeper an injury, the bigger the scar16. We therefore investigated if this correlation can 
be attributed to fascia by analyzing the extent of fibroblast contributions from the fascia and 
dermis in deep vs. superficial wounds. For this, we combined genetic lineage-tracing 
(En1Cre;R26mTmG ) with our anatomic fate-mapping chimeric grafts and performed superficial 
or deep injuries (Fig. 2a and see ‘Methods’). Fourteen days after, wound size of deep injuries 
were 1.7-times larger than superficial injuries (Fig. 2b-c). Fascia EPFs were 2-times more 
numerous in deep wounds, whereas dermal EPFs remained constant in both conditions (Fig. 
2d). The abundance of fascia EPFs in the wound directly correlated with wound size and 
thus scar severity, whereas dermal EPFs showed no correlation (Fig. 2e-f). No crossing of 
EPFs between these compartments was observed in uninjured controls, indicating that the 
influx of fascia EPFs was triggered by injury (Extended Data Fig. 3a-b).  
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Long-term tracing of fascia EPFs in wounds showed that they recede at 10 weeks (Extended 
Data Fig. 3c). This desertion from mature scars occurred through an apoptosis-independent 
mechanism, indicated by a low rate of cell death (<5 %) across earlier time points (Extended 
Data Fig. 3d-e). 
We then sought to place fascia EPFs in the framework of known lineage markers used to 
define different populations of wound fibroblasts such as CD24, CD34, DPP4, DLK1, and 
LY6A7, 10, 12. All markers were prominent in fascia EPFs and were surprisingly downregulated 
upon entering the wound in our graft experiments (Extended Data Fig. 4). Flow cytometry 
confirmed the higher DPP4, ITGB1, LY6A, and PDGFRα expression in fascia than dermal 
fibroblasts (Extended Data Fig. 5a-c). Sorted fascia EPFs also revealed low cellular 
heterogeneity, with the predominant population expressing LY6G+PDGFR + (87.0%) and 
DPP4+ITGB1+ (72.8%, Extended Data Fig. 5d). This broad marker convergence highlights 
fascia EPFs as the major cell source of wound fibroblasts. 
 
Provisional matrix emerges from fascia matrix 
We then looked at the fascia matrix itself. Second harmonic generation (SHG) signal and 
scanning electro-micrographs (SEM) revealed profuse coiled collagen fibrils in the fascia, 
indicative of a relaxed and immature matrix (Fig. 3a-b). Fractal measurements13 of the fiber 
alignments showed a more condensed matrix configuration in fascia than the stretched and 
woven dermal matrix (Fig. 3c). 
The immaturity of the fascia matrix motivated us to check if it could work as a repository for 
scar tissue. For this, we developed an incubation chamber that enabled live imaging of 
fascia biopsies over days (see ‘Methods’). Recording of SHG signal showed steering of the 
matrix at a rate of 11.4 µm/h (Fig. 3d-e and Extended Data Video 4). Assuming a similar rate 
in vivo, the fascia matrix could move ~2 mm in 7 days, accounting for the dynamics of 
provisional matrix deposition in mammals. 
To test if fascia matrix steers into wounds in vivo, we developed a technique to trace the 
fascia matrix in our chimeric grafts using NHS esters. (Fig. 3f and see ‘Methods’). Streams 
of traced matrix from the fascia already extended upwards and plugged the open wounds 
at 7 dpw (Fig. 3g and Extended Data Fig. 6a-b). Fascia-derived matrix covered 74.78 ± 
12.94% of total collagen content in the wound (Extended Data Fig. 6c). Our data indicated 
that individual fascia matrix fibers are not being pulled but rather pliable matrix is extended 
upwards to mold the wound. Advanced wound stages showed a label decline in specific 
regions of the wound suggesting an active remodeling process of the fascia-derived matrix 
(Extended Data Fig. 6d-f, and Extended Data Video 5). 
We then tested whether dermal matrix could be steered by double labeling our chimeric 
grafts. Only the fascia matrix plugged deep injury wounds (Extended Data Fig. 6g-j) while 
dermal matrix remained immobile in deep and superficial injuries, the later which healed via 
de novo matrix deposition (Extended Data Fig. 6k-l).  
To further prove that fascia matrix is steered into open wounds, we labeled the fascia matrix 
in situ prior to injury (Fig. 3h-i and “Methods”). Label-carrying matrix made most of the wound 
provisional matrix (Fig. 3j), which underwent remodeling during the first two weeks 
(Extended Data Fig. 7 a-b). Fractal measurements showed fascia fiber interfaces expanded 
by 3 dpw, ,changing from a parallel sheet arrangement, into a highly porous plug. This 
expansion is followed by contraction into thicker and more complex mature scar matrix 
architecture (Extended Data Fig. 7c-e). Surprisingly, traced matrix was also present in the 
eschar. Activated platelets infiltrated and clustered within fascia fibers before eschar 
formation (Extended Data Fig. 7f), indicating that the coagulation cascade occurs in parallel 
with fascia matrix steering. 
 
EPFs steer fascia matrix into wounds  
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To test if matrix steering from fascia is caused by EPFs, we blocked fascia by implanting an 
impermeable dual surface ePTFE membrane17 between the fascia and the PC in wounds of 
En1Cre;R26VT2/GK3 mice (Fig. 4a and ‘Methods’). Surprisingly, wounds with implants remained 
completely open whereas sham controls closed within 21 days (Fig. 4b). After two months 
EPFs trailed from the wound margins and under the membrane without generating scars 
(Fig. 4c and Extended Data Fig. 8a). Implants produced a transient inflammation that 
resolved even when the wound remained open. Two-month-old wounds with implants 
showed normal leukocyte and pro- and anti-inflammatory interleukins levels (Extended Data 
Fig. 8b-i), consistent with the clinical use of ePTFE as immunologically inert membranes. 
The coagulation cascade also was unaltered at the border between the dermis and the 
membrane (Extended Data Fig. 8j-k). These results indicate that the lack of scarring with 
ePTFE membranes does not reflect chronic inflammation or poor clotting, but a fascia 
steering blockade that is mediated by the fascia fibroblasts. These findings further support 
the notion that scar tissue is mostly fascia-derived, since in the absence of fascia 
movements, dermal EPFs or dermal matrix are unable to repair wounds. 
We then asked whether mechanical separation between dermis and fascia alone, without 
barrier implants, would affect matrix steering and scar formation. To address this question, 
we performed full excisional wounds in wild type mice and physically released the fascia 
below the PC around the wound (Fig. 4d). Wound closure from released-fascia wounds was 
significantly delayed, and wounds remained open early on similarly to those documented 
following membrane implantations (Fig. 4e-f).  
To definitively link fascia EPFs to matrix steering, we genetically ablated fascia EPFs using 
two separate strategies. First, we used a transgenic line that expresses the diphtheria toxin 
receptor (DTR) in a Cre-dependent manner (R26iDTR), allowing us to deplete cells 
expressing Cre recombinase upon diphtheria toxin (DT) exposure. We thus generated Cre-
expressing adeno-associated viral particles (AAV6-Cre) and injected them into the fascia of 
R26iDRT pups underneath freshly made full excisional wounds (Fig. 4g). Scar size from 
AAV6-Cre transduced mice treated with DT were significantly smaller than controls (Fig. 4h-
i). 
Secondly, we used En1Cre;R26iDTR double transgenics in which DTR expression is restricted 
to EPFs, making them susceptible to DT-mediated ablation. We corroborated the ablation 
of fascia EPFs in cultured biopsies 6 days after acute exposure to DT for 1h. Effective dose 
of DT prevented the normal increase in collagen fiber density observed in control samples 
and decreased 2.5-times the cell density (Extended Data Fig. 9a-c). Live imaging showed 
absence of any matrix steering after DT exposure (Extended Data Fig. 9d-e and Extended 
Data Video 6), confirming that fascia EPFs are pivotal for matrix steering. 
Next, we created chimeric grafts using dermis from wild-type mice and fascia from 
En1Cre;R26iDTR  mice. We ablated fascia EPFs using DT as before and labeled the matrix 
before transplantation (Fig. 4j). Ablation of fascia EPFs prevented matrix steering into the 
wound (Fig. 4k-l) and Instead labeled matrix remained in the fascia layer below. Altogether, 
our data conclusively demonstrate that fascia resident EPFs actively steer matrix to seal 
open wounds. 
To check if fibroblast proliferation preceded and was needed for matrix steering, we analyzed 
the proliferation rate in our matrix-tracing experiments. Expansion of the fascia gel beneath 
the wound occurred during the first days after injury, whereas cell proliferation peaked after 
a week (Extended Data Fig. 10a-c), indicating that proliferation is not required for matrix 
steering. Furthermore, treatment with a proliferation inhibitor had no effect on fascia matrix 
steering in vitro (Extended Data Fig. 9f-k and Extended Data Video 7). Our results prove 
that fascia matrix works as an expanding sealant that quickly clogs deep wounds 
independently of cell proliferation. 
 
Fascia and keloid share marker signatures 
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Human keloids show features of early and unresolved wounds, such as itchiness, 
inflammation, and pain18. This motivated us to investigate the presence of fascia fibroblasts 
in keloid tissue. We screened for markers present in keloids and compared them with 
healthy dermis and the connective tissue in the subcutaneous space (Fascia) of human skin 
across multiple anatomic locations (Fig. 5a-b). FAP and DPP4 markers were highly 
expressed in both fascia and keloids with low expression in dermis. The fascia-restricted 
protein NOV was also prominently expressed in both human and mouse fascia, as well as 
in human keloids and mouse scars (Fig. 5c-g). This preservation of fascia markers across 




Current wound healing models propose that dermal fibroblasts migrate into wounds and 
locally deposit matrix de novo onto the granulation tissue provided by the coagulation 
cascade. This provisional matrix is then remodeled into a mature scar. Based on our findings, 
we propose a revised model (Fig. 6) where, in deep injuries, fascia fibroblasts pilot their local 
composite matrix into wounds that, in coordination with the coagulation cascade, form the 
provisional matrix. Thus, instead of de novo matrix deposition by dermal fibroblasts, a “scar 
primordium” is steered by the fascia fibroblasts. Thus, fascia serves as an externum repono 
for scar-forming provisional matrix, which represent a much efficient mechanism to quickly 
seal large open wounds.  Previous studies have shown that the matrix undergoes motion 
during early development and organ morphogenesis19-22. To our knowledge, the extent and 
magnitude of matrix movements we document here have never been observed during injury 
or regenerative settings. Cultured dermal fibroblasts have been shown to pull and reorient 
individual collagen or fibronectin fibers locally in cultured plates as well as in 3D in vitro 
assays23-24.  Whereas, our findings reveal an unprecedented dynamic and scale of motion 
for composite tissue matrix during injury that is mediated exclusively by specialized 
fibroblasts of the fascia. 
Our findings on fascia contribution to large scars and its blockage leading to chronic open 
wounds, indicates that the spectrum of poor and excessive scarring in the skin, such as 
diabetic and ulcerative wounds, as well as hypertrophic and particularly keloid scars might 
all be attributed to fascia. Indeed, the subcutaneous fascia varies widely in different species, 
sex, age, and anatomic skin locations25. In some mammals, the superficial fascia is loose, 
whereas in scar-prone species like human, dog and horse, the superficial fascia is thicker. 
Human fascia further varies in thickness on different regions of the body26. For example, 
lower chest, back, thigh and arm have much thicker and multi-layered membranous sheets, 
and it is these anatomic sites that are prone to form large and keloid scars. Whereas other 
sites such as the foot have a much thinner or inexistent fascia27. Understanding the 
topographic anatomy of the fascia layer may help explain scar phenotypes and severities, 
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Fig. 1. Fascia is a major cellular source for wounds. a. Chimeric grafts to determine contributions of 
dermis and fascia. b. Percentages of TdTomato+ or GFP+ cells from total labeled cells in the wound 
and wound margin. Mean and SEM, n= 26 images from 4 biological replicates. One-way ANOVA, 
multiple comparison Tukey test, confidence interval = 95%. c. Wound showing skin- and fascia-
derived cells at 14 dpw. d-e. Immunolabeling and contributions to myofibroblasts (αSMA), nerves 
(TUBB3), blood vessels (PECAM1), monocytes/macrophages (MOMA-2), and lymphatics (LYVE1). 
Mean and SEM, n= 4 (LYVE1), 5 (αSMA, TUBB3, and MOMA-2), or 8 (PECAM1) images from 4 
biological replicates. Unpaired two-tailed T-test, confidence interval = 95%. Dotted lines delimitate 





Fig. 2. Fascia EPFs dictate scar severity. a. Dermal vs fascia EPFs chimeric grafts. b. Images 
showing fascia EPFs (left) or dermal EPFs (right) in wounds after a deep (top) or superficial injury 
(bottom). c. Wound size. Mean with SEM, n= 70 (deep) and 53 (superficial) images analyzed from 
5 biological replicates. Unpaired, two-tailed T-test, confidence interval = 95%. d. Fascia and dermal 
EPFs numbers. Mean with SEM, n= 27, 32, 27, and 22 images analyzed from 5 biological replicates. 
Unpaired, two-tailed T-test, confidence interval = 95%. e-f. XY plots of EPFs fractions and wound 
size from fascia (e) and dermal EPFs (f). n= 57 (e) and 48 (f) images analyzed from 5 biological 
replicates. Two-tailed R2 Pearson correlation, confidence interval = 95%. Dotted lines delimitate 





Fig. 3. Fascia matrix steers into wounds. a. SHG (a) and SEM images (b) of fascia (left) and dermis 
(right) showing matrix arrangements, representative images of 3 biological replicates. c. Fractal 
dimension and lacunarity values from SHG images. n = 5 and 3 images analyzed from 3 biological 
replicates. Unpaired two-tailed T-test, confidence interval = 95%. d. Time-lapse images of fascia in 
culture at time 0 (left), and 30 hours (right). Representative video from at least three independent 
experiments. e. Contraction rate from the SHG and autofluorescence. Data obtained from extended 
data video 4. f. Fascia matrix labeling with AF647 NHS ester in chimeric grafts. g. 7 dpw images 
showing fascia matrix covering the wound, representative image of at least three biological replicates. 
h. In situ fascia matrix tracing experiment using FITC NHS ester. i. Uninjured controls showing 
specificity of the labeling in fascia, representative sample of at least three biological replicates. j. 7 
dpw images showing fascia matrix covering the wound area, representative samples of at least three 
biological replicates. Arrowheads indicate the original injury. Brocken lines delimitate dermis (g and 






Fig. 4. Fascia EPFs steer scar primordium into wounds. a. ePTFE implants to block fascia steering. 
b. ePTFE-implanted or sham wound closure (left) determined from photographs (right) at specified 
time points. Mean with SEM, n = 3 biological replicates. Unpaired two-tailed T-test, confidence 
interval = 95%. c. Sham (left) or ePTFE-implanted (right) wounds at 63 dpw. Trichrome staining (top) 
and collagens immunolabeling (middle). Magnifications (cI-II, bottom) show multiclonal dermal EPFs. 
Representative images from 3 biological replicates. d. Fascia release experiment. e. Fascia-
released or control wound closure (left) determined from photographs (right) at specified time points. 
Mean with SEM, n = 8 (0-3 dpw), 6 (5 dpw), 4 (7 dpw), and 2 (10 dpw) images from 8 biological 
replicates. Unpaired two-tailed T-test, confidence interval = 95%.  f. Trichrome stained wounds at 3, 
5, and 7 dpw (from top to bottom) from control (left) or fascia-released wounds (right). Representative 
images from 8 biological replicates. g. Fascia cell depletion in R26iDTR neonates. h. Trichrome 
stained wounds at 7 dpw in GFP- (left) or Cre-transduced (right). Arrows indicate GFP-positive cells. 
Representative images from 3 biological replicates. i. Scar-length measurements. Mean with SEM, 
n = 4 and 8 sections from 3 biological replicates. Unpaired two-tailed T-test, confidence interval = 
95%.  j. Fascia EPFs depletion in chimeric grafts with fascia matrix labeling. k. Immunolabeling for 
collagens, and fascia matrix in control (left) or DT-treated (right) grafts. Representative images from 
3 biological replicates. l. Matrix labeling coverage. Mean with SEM, n = 6 sections from 3 biological 
replicates. Unpaired two-tailed T-test, confidence interval = 95%. Dashed lines delimit the implant. 
Dotted lines delimitate the wound. Arrowheads indicate original injury. Arrow indicates remaining 
labeled fascia matrix in DT-treated grafts. Scale bars = 50 microns (cI and cII), 200 microns (h), and 





Fig. 5. Marker signature in keloids and fascia. a-b. macroscopic pictures and trichrome staining of 
human back and abdominal skin showing fascia layers embedded in subcutaneous tissue. Arrows 
indicate the fascia. Representative images from 4 independent samples c. Co-immunolabeling for 
DPP4-CD44, FAP, and NOV-αSMA on fascia, dermis, and keloids of human back skin. d. Relative 
fluorescence intensity (RFI) normalized to the dermis. Mean with SEM, n= 4 images analyzed from 
4 biological replicates. One-way ANOVA with Tukey’s test, 95% Confidence interval. e-f. 
Immunostaining for NOV on En1Cre;R26mTmG 14 dpw scars. g. Relative fluorescence intensity 
normalized to the dermis. Mean with SEM, n = 6 images of 3 biological replicates. One-way ANOVA, 
Tukey’s test, 95% Confidence interval. Dotted and broken lines delimitate scar and fascia 





Fig. 6. Revised wound healing model. Superficial injuries heal by the classical fibroblast migration 
and de novo matrix deposition process. In response to a deep injury, fascia fibroblasts steer their 
surrounding tissue up into wounds. Fascia-derived macrophages, endothelial and peripheral nerves 
rapidly clog the open wound. In coordination with the platelet response, the fascia matrix serves as 





Extended data figures 
  
Extended Data Fig. 1. Fate mapping of fascia cells with DiI. a. DiI labeling of fascia cells. b. 
Histology showing DiI+ cells in uninjured controls (left) and 14 dpw (right). Representative 
images of 5 biological replicates. c. Immunolabeling (top) and fractions (bottom) of DiI-
positive cells expressing mesenchymal/fibroblast markers ITGB1 (CD29), ER-TR7, THY1 
(CD90), and PDGFRA, d. Immunolabeling (top) and fractions of DiI-positive 
monocytes/macrophages (MOMA-2), lymphatics (LYVE1), endothelial (PECAM1), and 
nerves (TUBB3). Mean with SEM, n= 5 (4 in MOMA-2) images analyzed from 5 biological 
replicates. Lines delimitate PC. Dotted line delimitates the wound. Scale bars = 200 microns. 





Extended Data Fig. 2. Fascia EPFs traverse PC. a. Gating strategy for fibroblasts analysis. 
b. Percentages of fibroblasts (Lin-) and lineage-positive cells in fascia and dermis. Mean 
and SEM, n= 4 independent experiments. Unpaired two-tailed T-test, confidence interval = 
95%. c. Scatter plots of EPFs (GFP+, Lin-) and ENFs (TdTomato+, Lin-) in fascia and dermis. 
Representative plots of three independent experiments. d. EPFs and ENFs fractions in 
fascia and dermis. Mean with SEM, n= 4 independent experiments. Two-way ANOVA, 
multiple comparison Tukey test, confidence interval = 95%. e. Endothelial (PECAM1+), 
lymphatics (LYVE1+), macrophages (F4/80+), and nervous (NGFR+) fractions in fascia and 
dermis. Mean with SEM, n= 3 biological replicates. Two-way ANOVA, multiple comparison 
Tukey test, confidence interval = 95%. f-k. Representative images of 3D rendered 
En1Cre;R26mTmG or En1Cre;R26VT2/Gk3 back skin fascia from at least three biological replicates. 
f. Lateral view (left) and cross-sections (right) of adult fascia. g. Top view (ventral side up) 
of neonate back-skin. h. Top side view (top) and lateral cross-section (bottom) at the forelimb 
junction showing EPF traversing the PC. i. Top view at a muscle breach showing EPFs in 
both locations. j. Top view at a muscle opening where nerves pass through and polyclones 
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of EPFs reside. k. Top view (top, epidermis side up) and lateral cross-section (bottom) of an 
adult superficial wound (3 dpw). Brocken lines delimitate the PC muscle layer. Dotted lines 
delimitate the epidermis. Scale bars = 1500 microns (g), 100 microns (f, i-j), and 500 microns 
(k). PC = Panniculus carnosus, v = vessels, nb = nerve bundles. 
 
  
Extended Data Fig. 3.  Fascia EPFs maintain position in steady conditions and recede from 
wounds over time. a. Dermal versus fascia EPFs chimeras in uninjured conditions. b. Fascia 
(left) or dermal (right) EPFs-traced chimeras. Representative images of 3 biological 
replicates. c. 70 dpw scars from deep injuries of fascia EPFs-traced chimeras 
immunolabeled for DPP4. Representative images of 3 biological replicates. d. Cleaved-
CASP3 expression in wounds from fascia (left) or dermal (right) EPFs-traced chimeras from 
deep (top) or superficial (bottom) injuries at 14 dpw. e. Fractions of fascia or dermal EPFs 
in the wound, dermis, or fascia control regions positive for cleaved-CASP3. Mean with SEM, 
n= 6 and 5 (fascia and dermal EPF respectively) images analyzed from 5 biological 
replicates. Lines delimitate the border between fascia and dermis. Dotted lines delimitate 





Extended Data Fig. 4. Fascia EPFs express wound fibroblast markers. a. Dermal versus 
fascia EPFs-traced chimeras with two injury conditions. b-f. Representative immunolabeling 
against the fibroblast markers DPP4 (b), DLK1 (c), CD24 (d), CD34 (e), and LY6A (f) from 4 
biological replicates. g. Areas analyzed (top) for marker positive EPFs quantification 
(bottom). Mean with SEM, n= 5 images analyzed from 4 biological replicates. One-way 
ANOVA, multiple comparison Tukey test, confidence interval = 95%. Dotted lines delimitate 





Extended Data Fig. 5. Differential expression of classical markers on fascia and dermal 
fibroblasts. a. Gating strategy for fibroblast (Lin-) cytometry. b. Histo-plots of fibroblasts 
markers expression in fascia or dermis derived fibroblasts from three biological replicates. 
c. Fraction of marker positive cells from total fibroblast population. Mean with SEM, n= 3 
biological replicates. Unpaired two-tailed T-test, confidence interval = 95%. d. Gating 
strategy for fascia EPF (Lin-, GFP+) sorting and expression detection of LY6A and PDGFR1, 






Extended Data Fig. 6. Fascia but not dermal matrix steers into wounds. a. Matrix tracing in 
chimeric grafts. b. Grafts at 7dpw immunolabeled against COLLAGEN I, III, and VI. 
Representative image of 3 biological replicates. c. Label coverage fraction from total 
collagens in the wound at defined time points. Mean with SEM, n= 4 and 9 sections analyzed 
from 3 biological replicates. Unpaired two-tailed T-test, confidence interval = 95%. d. 
Wounds at 14 dpw immunolabeled against collagens. Representative images of 3 biological 
replicates. e-f. High magnifications of inserts in “d”. g-h. Double matrix tracing in deep-
injured Dermal EPF-traced grafts at 7 dpw. Representative image of 3 biological replicates. 
i-j. Double matrix tracing in deep-injured Fascia EPF-traced grafts at 14 dpw. Representative 
image of 3 biological replicates. k-l. Double matrix labeling in superficial-injured Dermal 
EPF-traced grafts at 14 dpw immunolabeled against collagens. Representative image of 3 
biological replicates. Dotted lines delimit the wound. Arrowheads mark the original injury. 
Continuous lines delimitate the epidermis dermis margin. Scale bars = 500 microns (b), 100 




Extended Data Fig. 7. Fascia matrix forms the eschar and gets remodeled in the wound. a. 
Left: In situ matrix tracing and COLLAGENI+III+VI immunolabeling at defined time points 
after wounding. Representative images of 3 biological replicates. Right: Subsampled fractal 
dimension maps of the FITC signal at the uninjured, 3, and 7 dpw, and from collagens signal 
at 14 dpw. b. Matrix label coverage from total COLLAGEN I+III+VI signal in the wound. Mean 
with SEM, n= 3, 4, 7, and 4 sections analyzed from 3 biological replicates. One-way ANOVA, 
Tukey multiple comparisons. c-d. Average fractal dimension (c) and lacunarity (d) from 
subsampled maps. Mean with SEM, n= 5, 5, 8, and 3 images analyzed from 3 biological 
replicates. One-way ANOVA, Tukey test. Confidence interval = 95%. e. Scatter plot of 
average fractal dimension and lacunarity values. f. In situ matrix tracing and SELP 
immunolabeling at defined time points after wounding. Representative images of 3 biological 
replicates. Brocken line separates dermis from fascia. Dotted lines indicate the wound. Scale 









Extended Data Fig. 8. Inflammation resolution and coagulation stay unaffected during fascia 
blocking. a. Sham (left) or ePTFE-implanted (right) wounds at 7 (top) or 63 dpw (bottom) 
immunolabeled for COLLAGEN I-III-VI. Representative images of 3 biological replicates. b-
i. Immunolabelings (left) and fractions (right) of immune cells (PTPRC+, b), neutrophils 
(LY6G+, c), T cells (CD3+, d), NK cells (NCR1+, e), B cells (CD19+, f), macrophages and 
monocytes (MOMA2+, g), and cells expressing the pro- and anti-inflammatory cytokines 
(IL12 and IL4 respectively, h-i). Mean with SEM, n= 3 images analyzed from 3 biological 
replicates. Unpaired two-tailed T-test, confidence interval = 95% (b). One-way ANOVA, 
Tukey test, confidence interval = 95% (c-i). j. Activated platelets (SELP) in 7 dpw sham and 
ePTFE-implanted wounds. Representative images of 3 biological replicates. k. Mean gray 
value of SELP signal. Mean with SEM, n = 3 images analyzed from 3 biological replicates. 
Two-tailed Student T-test, confidence interval = 95%. Dotted lines delimitate the wound area. 







Extended Data Fig. 9. EPFs steer matrix in vitro independently of proliferation. a. 
En1Cre;R26iDTR biopsies at day 0 and 6 after short treatment with DT or vehicle 
immunolabeled for COLLAGEN I, III, and VI. Representative images of 3 replicates. b. 
Collagens density. Mean with SEM, n= 3 images analyzed from 3 biological replicates. Two-
way ANOVA, multiple comparison Tukey test, confidence interval = 95%. c. Cell density. 
Mean with SEM, n = 3 images analyzed from 3 biological replicates. One-way ANOVA, 
multiple comparison Tukey test, confidence interval = 95%. d-e. Time-lapse images (d) and 
contraction rate (e) of En1Cre;R26iDTR neonate fascia biopsy in culture treated with DT for 1h. 
Representative samples from 3 replicates. Contraction values obtained from extended data 
video 4 and 6. f. Fascia biopsies treated with Etoposide and immunolabeled for MKI67. g. 
Fraction of MKI67+ cells. Mean with SEM, n= 3 images analyzed from 3 biological replicates. 
One-way ANOVA, Dunnett multiple comparisons, confidence interval = 95%. h-i. Time-lapse 
images (h) and contraction rate (i) of neonate fascia biopsy in culture treated with 100μM 
Etoposide. Representative samples from 3 replicates. Contraction values obtained from 
extended data video 4 and 7. j. Mean with SEM matrix contraction velocity during the first 
25 h of imaging. n= 25 values from extended data video 7. Two-tailed Student T-test. 
Confident interval = 95%. Lines show the distance between two tracked points in the SHG 





Extended Data Fig. 10. Fascia matrix steering precedes proliferation in vivo. a. In situ fascia 
matrix labeling and EdU pulses. b. EdU detection in sections at defined time points. c. 
Fraction of EdU+ cells in the wound from total EdU+ cells. Mean with SEM, n= 3, 4, 6, and 4 
images analyzed from 3 biological replicates. One-way ANOVA, Tukey multiple comparisons. 
Arrows indicate EdU-positive nuclei. Arrowheads indicate the original injury site. Brocken 






All videos are available online together with the publisher’s version of the manuscript 
Extended data video 1. 3D reconstruction of adult En1Cre;R26mTmG fascia. EPFs in green 
and SHG in cyan. 
Extended data video 2. 3D reconstruction of neonate En1Cre;R26mTmG back-skin and fascia. 
EPFs in green and TdTomato in red. 
Extended data video 3. 3D reconstruction of adult En1Cre;R26mTmG back-skin wound bed 3 
dpw. EPFs in green and TdTomato in red. 
Extended data video 4. Time-lapse of 3D rendered P0 C57BL6/J fascia biopsy in culture. 
Second harmonic generation (SHG) in cyan and autofluorescence in green. 
Extended data video 5. 3D reconstruction of day 14 wounds after transplantation of chimeric 
grafts with labeled matrix. 
Extended data video 6. Time-lapse of 3D rendered P0 En1Cre;R26iDTR fascia biopsy in culture 
treated with an acute exposure of 2 μg/ml of diphtheria toxin. Second harmonic generation 
(SHG) in cyan and autofluorescence in green. 
Extended data video 7. Time-lapse of 3D rendered P0 C57BL6/J fascia biopsy in culture 
treated with 100 μM etoposide. Second harmonic generation (SHG) in cyan and 
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